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1 Metabolic engineering of Saccharomyces cerevisiae using antisense hammerhead 
ribozymes 
1.1 Introduction 
 
In the last few years the development of new strategies for delivering ribozymes has been 
followed with interest. The use of ribozyme technology has enormous potential in research 
and biotechnology due to the advantages of ribozymes over other genetic approaches. In 
mammalian cells this technique has been used successfully and its application in cancer 
treatment as well as gene-therapy appears to be a new goal in pharmaceutical research. 
However, in Saccharomyces cerevisiae only few reports showed that a catalytic active RNA 
is able to reduce the gene expression. 
The strategy to improve the yield of a yeast metabolic product by down-regulation of the 
expression of a specific gene by cleaving its mRNA using antisense-ribozymes is promising. 
In contrast to direct mutational modification or disruption of a gene, this technique allows the 
temporary limited manipulation of genes essential for vitality and/or viability of the organism.  
Moreover, when using a regulatory system for ribozyme delivery, it should be possible to 
reduce gene expression at a specific optimal stage in the fermentation process. This chapter is 
focused on the description of the small catalytic RNA, the hammerhead ribozyme as a trans-
acting factor to reduce gene expression, as well as considerations and requirements to have 
high efficient catalysis in yeast cells. 
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1.2 General features of hammerhead ribozymes 
1.2.1 History 
 
Ribozymes (RNA enzymes) are RNA molecules with catalytic activity. The first naturally 
occurring ribozyme activity was detected in the self-splicing group I intron of Tetrahymena 
thermophila, located in the nuclear gene for the large ribosome RNA. The intron has an 
autocatalytic unit. This unit makes a self-excision and the flanking exons are ligated to form a 
mature RNA. Shortly afterwards, the RNase P enzyme was purified from Escherichia coli in 
which the 400 nucleotide RNA component of RNase P was shown to cleave its substrate (pre-
tRNA) in the absence of the protein subunit. The catalytic RNAs were divided into six main 
groups: (1) Ribozymes derived from self-splicing Tetrahymena group I introns, (2) RNA 
component of RNase P, (3) RNAs of the hepatitis & virus, (4) RNAs transcripts of the 
mitochondrial DNA plasmid of Neurospora, (5) Hairpin ribozymes, and (6) Hammerhead 
ribozymes (Gaughan & Whitehead, 1999). In addition, structural and chemical analyses 
strongly suggest that the ribosomal RNA is a ribozyme and the RNA components of the 
spliceosome appear to have catalytic activity (Takagi et al., 2001). 
 The hammerhead ribozyme is the smallest catalytic RNA motif observed so far and also 
the simplest in terms of structure and requirements. It was originally detected in RNA 
molecules of several plant viroids and viruses, such as tobacco ringspot virus (TRSV), 
avocado sunblotch virus (ASBV) and in satellite RNAs. Approximately 16 hammerhead 
motifs are known in the plus and minus strands of these plant pathogens and three other 
motifs are found in the satellite 2 RNAs from salamanders Triturus vulgyris, Ambystona 
talpoideum and Amphiuma tridactylum (Tanner, 1999). These RNAs can mediate self-
cleavage in the course of their replicative cycle. This process requires highly specific 
intramolecular cleavage of concatemeric RNAs, which result from a rolling cycle replication 
mechanism and leads to monomeric units (Amarzguiogui & Prydz, 1998; Eckstein et al., 
 11 
2001). A sequence of only ~50 nucleotides was found to be the minimum requirement for 
self-cleavage. 
 
 
1.2.2 Secondary structure  
 
The molecular structure of the hammerhead ribozyme is probably the most studied of all 
ribozymes. The name hammerhead was given based on the secondary structure of the self-
cleaving model, which was reminiscent of the head of a hammerhead shark for its Australian 
discoverers (Haselhoff & Gerlach, 1988). The model consists of three putative stems (I, II, 
and III) two of which are flanking the susceptible phosphodiester bond, and two single-
stranded loop regions which are highly conserved among different self-cleaving RNAs and 
participate in catalysis. A GUC triplet in stem III sequence immediately preceding the 
phosphodiester bond is also highly conserved (Tanner, 1999). Haselhoff and Gerlach 
determined the first hammerhead ribozyme consensus nucleotide sequence by analyzing the 
minimum number of nucleotides required for cleavage (Haselhoff & Gerlach, 1988). They 
identified non-conserved nucleotides in stem I and III that determined specific binding to 
RNAs. Furthermore, the catalytic core appears to have two stretches of highly conserved 
sequence: 5’-CUGANGA and 5’GAAG. These sequences are highly sensitive to any change 
in terms of catalytic activity. 
 12 
 
 
 
Figure 1: Minimal consensus structure for a trans-hammerhead ribozyme. N represents 
any nucleotide; H represents any nucleotide except G. R is purine and Y is pirimidine. 
 
 
In vivo, the cleavage in self–cleaving RNAs occurs in cis; however, the hammerhead 
ribozyme can be divided into two separate RNA components that hybridize via helices I and 
III (See fig. 1). Thus, the cleavage reaction proceeds in trans. In a trans-cleavage reaction, the 
RNA to be cleaved is called the target or substrate, and the catalytic active RNA, enzyme is 
the ribozyme. 
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1.2.3 Mechanisms and catalysis 
 
Many experiments have been performed to determine the mechanisms of cleavage and the 
role of divalent cations on catalysis. Naturally, the hammerhead ribozyme catalyzes the 
endonucleolytic cleavage of RNA via a mechanism that involves nucleophilic attack by a 2’-
OH group on the phosphorus of the neighboring phosphodiester bond, generating 5’-OH and 
2’, 3’ –cyclic phosphate termini. This reaction seems to be accompanied by an inversion of 
the configuration of the phosphorus atom suggesting a direct in-line attack with development 
of a pentacoordinate transition state. Hammerhead ribozymes have a basic requirement for 
divalent metal ions, such as Mg 2+. In 1996 Scott and collaborators captured the structure of a 
catalytic intermediate (Fig. 2). The RNA structure was crystallized in the presence and 
absence of Mg2+. The ribozyme could cleave itself when Mg2+ was added showing 
conformational changes placed around the active site (Scott et al., 1996).  
The role of Mg2+ in the molecular mechanism of ribozyme catalysis has been widely 
investigated; however the number of Mg2+ ions involved in such an event is unknown. Until 
now two theories have been developed. 
A single-metal-ion mechanism was suggested (Fig. 3). Analyzing the differences in the 
rates of cleavage observed in the presence of metal ions, as well as the relationship at certain 
pH between the ∆pKa values of the corresponding metal ions in water, support the idea that 
Mg 2+ acts as a general base catalyst (Takagi et al., 2001). 
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Figure 2: Hammerhead ribozyme schematic crystal view (Scott et al., 1996). The RNA 
backbone is colored in blue. The nucleotides of the catalytic pocket are shown in green, and 
the magnesium cations in yellow highlighted by van der Waals spheres. The cleavage site is 
indicated by the red portion of the RNA backbone. 
 
However, a double-metal-ion mechanism is also described, in which one-metal-ion 
coordinates to the 2’-oxygen, and the other acts as Lewis acid by binding to the 5’ oxygen on 
the leaving group, see fig. 3 (Vaish et al., 1998). This theory might also explain reactions 
catalyzed by hammerhead ribozymes. The existence of such a mechanism can be supported 
by cleavage experiments where Mg2+ ions showed to play different roles on catalysis (Lott et 
al., 1998). 
 15 
 
A                                                                      B 
 
Figure 3: Schematic representation of possible mechanisms for the Mg2+-catalyzed 
cleavage reaction of hammerhead ribozymes. (A). One-metal-hydroxide-ion model. (B) Two-
metal-ion model (Hammann & Tabler, 1999). 
 
 
Furthermore, under extreme conditions the hammerhead ribozyme can also use 
monovalent cations for catalysis (Curtis & Bartel, 2001). These findings indicate that the 
hammerhead ribozyme catalysis might operate via a variety of cleavage mechanisms. 
Bounded metal-ions could act as either Lewis acids or bases depending on the conditions of 
reaction. However, the mechanistic details still seem to be under debate (reviewed by Blount 
& Uhlenbeck, 2002; Takagi et al., 2001; Tanner, 1999). 
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The mechanism of a hammerhead ribozyme-catalyzed reaction can be divided in three 
steps: substrate interaction, cleavage and dissociation. Therefore, it is possible to analyze the 
steady–state kinetic of this reaction with a standard Michaelis-Menten model, establishing the 
individual constants for Km and kcat for the reaction (Fig. 4).  
 
(1) E + S→ E + P1+P2 
(2) Km =K association < K cleavage → K dissociation  
 
 
 
Figure 4: Mechanism of association, cleavage, and dissociation by trans-acting 
hammerhead ribozymes. The hammerhead ribozymes are able to cleave another target 
molecule immediately after the first reaction and the cleavage products might be degraded by 
RNases. 
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In this system binding and release of substrate and product follow the kinetics 
expected for formation and dissociation of standard Watson-Crick duplexes in the stem 
regions (McKay & Wedekind, 1999). Based on this model it was demonstrated that the 
association rate of ribozyme for the reaction with long substrates (mRNAs) may be slowed or 
suppressed due to the presence of secondary structures in the target RNA that may hamper the 
association step. The cleavage rate reflects the velocity of the phosphodiester bond cleavage 
and depends on salt concentration, pH and temperature. The turnover conditions can be single 
or multiple depending on the substrates and ribozymes concentrations. Single turnover is 
characterized by the excess number or ribozymes over long mRNA substrate (reviewed by 
Muotri et al., 1999). Multiple turnover takes place in excess of substrate (short 
oligonucleotides) over the ribozyme; a hammerhead ribozyme molecule can catalyze the 
cleavage of several RNA molecules. The reaction rate for single turnover is slower in several 
orders of magnitude than multiple turnover rates. 
 18 
 
1.2.4 Design of efficient hammerhead ribozymes 
 
The hammerhead ribozymes can be engineered to cleave any target RNA; however, 
during design some structural properties need to be considered such as: (i) the lengths of the 
arms at the complementary regions, (ii) the structure of the RNA in the target region, and (iii) 
the nucleotides surrounding the phosphodiester bond at the cleavage site. Sequence 
modifications can affect the turnover and the stability of the hammerhead ribozyme as well as 
the possible bindings of cellular proteins, which could also have an important influence on the 
in vivo catalytic reaction (Rossi, 1999).  
The only requirement for the target is the presence of a three-nucleotide motif NUH, 
where N is any nucleotide and H is any nucleotide but G. Different triplet-flanking sequence 
combinations can be designed. However, the resulting variants can differ drastically when the 
kinetic of the cleavage reactions are tested. Therefore, most researchers rely on GUC, since 
this motif is found most frequently among the natural hammerheads and has high catalytic 
rate (Amarzguioui & Prydz, 1998). 
Many concepts can be used in order to design the length of the antisense arms. It is now 
known that five to eight nucleotides on either side are the minimum sequences required to 
perform a good and specific process (Amarzguioui & Prydz, 1998). Lieber and Strauss (1995) 
have determined that the most active ribozymes in vitro had a consecutive complementary 
stretch with a substrate of only 15 nt, i.e. 7 and 8 nt on either arm. They implemented a new 
strategy for selection of accessible cleavage sites in target RNAs by using a library of random 
sequences that flank the unique sequence of a hammerhead. The in vivo analysis of the 
ribozymes variants showed that the strongest inhibition effect is close to 99% when the 
shortest stretch complementarities (7 and 8 nt on either side) are used. 
 19 
 
When multiple turnovers are desired, i.e. one molecule will cleave several substrate RNA 
molecules, the lengths of the arms directly influence the association and dissociation steps. 
Obviously, there is a size window for the antisense flanks of a ribozyme where association 
and dissociation simultaneously proceed well (Hammann & Tabler, 1999). 
 
Analyzing the minimal length for the binding of helix I and helix III in order to achieve 
the optimal in vitro cleavage rate, it was also demonstrated that asymmetric hammerhead 
ribozymes cleaved more rapidly than symmetric hammerheads. The enhancement on the 
cleavage rate when one of the helices is relatively weak, i.e. one complementary flank is 
shorter than the other, is consistent with a pre-equilibrium between active and inactive 
conformations of the ribozyme-substrate complex. Hence, it was observed that a relatively 
short helix I of about 5 bp accompanied by a helix III of 10 bp are required for fast in vitro 
cleavage rates (Hendry & McCall, 1996). 
 
Asymmetric hammerhead ribozymes have also been constructed with a short helix I where 
only three nucleotides are required, in combination with a long helix III. This new version of 
a hammerhead ribozyme is divided into two functional domains, the 3’ domain responsible 
for hybridization and the second 5’ domain responsible for catalysis. The localization of the 
catalytic domain at the 5’ end facilitates the construction of a hammerhead ribozyme variant 
by a simple PCR step (Hammann & Tabler, 1999). 
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1.2.5 Selection of the target sites 
 
A good choice of an appropriate ribozyme target site is one of the most critical steps in 
hammerhead design. The tertiary and secondary structures of RNAs as well as the association 
to RNA-binding proteins in vivo can have a negative effect on the catalytic activity. 
Therefore, many approaches have been directed to identify a possible target through the 
prediction of the secondary structure of the target RNAs. The most common RNA folding 
program is MFOLD based on the algorithm developed by Zuker. This program predicts a 
selection of several structures for one RNA sequence, which might differ significantly from 
each other with respect to the fold, although they differ only slightly in free energy (Zuker, 
1994). 
 
The rules for target selection through computer programs have been analyzed. The ideal 
optimal location of a target must consider: (i) the target sequences embedded within a long 
base-paired stem (double stranded region) have to be avoided, (ii) the sites should fall within 
a loop that is not smaller than four nucleotides, (iii) one or preferably both of the 5’ and 3’ 
ends of the antisense segment should fall within a single stranded rather than a stem region, 
(iv) target sequences within the first several hundred nucleotides of a large RNA molecule are 
favored (more details below), and (v) short antisense segments with 7-12 nucleotides for each 
arm of a hammerhead ribozyme, as well as 12-23 nucleotides for an antisense oligo give best 
results (Jiagang & Lemke, 1998). 
 
The selection of target sequences located at the 5’ end is supported by different 
approaches. The regions surrounding the translation-initiation site and splice-sites have been 
targeted so far. In these regions, the RNA may be more accessible to hybridization by 
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ribozymes due to the need for relatively open structures for binding of the translation 
machinery and spliceosomes respectively. On the contrary, the downstream coding region has 
been considered less efficient for binding ribozymes since the moving translation machinery 
may displace slow-cleaving ribozymes before cleavage can occur (Amarzguioui & Prydz, 
1998). 
 
Computer programs predict secondary structures but they are not able to select the most 
accessible sites in the targets. Hence other approaches must be considered. 
 
Experimentally, the use of random ribozymes libraries is the most straight-forward 
approach to target identification and is the best option to find the most efficient ribozymes 
against any target. However, practical difficulties arise because ribozymes are present in such 
small amounts in the cell that the detection of the cleavage products is a very laborious 
procedure. Therefore, the cloning and sequence analysis of the reverse transcription-
polymerase reaction (RT-PCR) products are necessary (Lieber & Strauss, 1995). All the 
tested cleavage sites were predicted as taking place in single stranded regions by computer 
programs. This suggests that the ribozymes should be targeted to predicted single stranded 
regions only. 
 
Enzyme as well as chemical assays have been used for in vitro detection of the targets. 
The principle of these assays is that regions accessible for hybridization with oligonucleotides 
should also be accessible to ribozymes. The transcripts are incubated with RNase H and 
decadeoxyoligonucleotides and the RNase H cleaves the sites accessible for hybridization 
(due to the ability of RNase H to cleave RNA strands only in RNA/DNA hybrids). The sites 
can be identified by the size of the labeled cleavage product (Birikh et al., 1997). For human 
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transcripts, this technical approach was shown to be better for selection of active target sites 
than the use of ribozymes designed by computer programs. 
 
Nevertheless, the in vivo situation is different because many proteins bind the RNA and 
can either mask the potential targets and/or influence the structure of the RNA in its non-
complex form. Heterogeneous ribonuclear proteins (hnRNPs) and small nuclear ribonuclear 
proteins (snRNPs) in the nucleus and the translational machinery in the cytoplasm as well 
might sequester the RNA transcripts in a form that hampers the accessibility of ribozymes to 
their respective targets. 
 
Referring to the method mentioned above, another strategy has been developed in order to 
take advantage of the RNA in its native, protein-associate state. Therefore, the native RNAs in 
cellular extracts associated with the proteins should be the best substrates for selection of the 
sites, which can hybridize with oligonucleotides. The use of cell extracts prepared from cells 
which are expressing the RNA of interest is the most important component in this system. The 
outcome of this approach was in accordance with results obtained in vivo (Castanotto et al., 
1999). 
 
Furthermore, the consensus sequence AUGUC, placed at the start codon is frequently 
found in a considerably number of yeast genes. Experimental approaches showed that this 
GUC triplet is contained in an accessible region and therefore can be used for designing trans-
acting hammerhead ribozymes in S. cerevisiae (Ferbeyre et al., 1995). 
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1.3 Delivering ribozyme in yeast 
 
Although the regulation of gene expression in animals and plant using antisense 
ribozymes is widely reported, there are only a few reports where hammerhead ribozymes 
were used to influence gene expression in S. cerevisiae (Table 1). That might be ascribed to 
the efficiency of homologous recombination in S. cerevisiae that permits replacement, 
disruption or altering of the sequence at any chromosomal site. However, the enormous 
advantages obtained through application of trans-acting ribozymes in gene therapy of 
mammalian cells and the alteration of traits in plants have recently suggested the creation of 
simple in vivo models to evaluate these technologies appropriately (Arndt & Atkins, 2001). 
 
Table 1: Approaches carried out in vivo to study antisense and trans-acting ribozymes 
to mediate gene suppression in Saccharomyces cerevisiae. 
Target gene Antisense/Ribozyme Reference 
CAT 5’ Antisense, nonaribozyme; cis- 
and trans-hammerhead ribozymes 
Atkins & Gerlach (1994) 
ADE1 Cis- and trans-hammerhead 
ribozymes 
Ferbeyre et al.(1995) 
ADE1 Trans-hammerhead ribozymes 
expressed under control of 
galactose-inducible promoter 
Ferbeyre et al. (1996) 
U3 RNA Trans-hammerhead ribozyme 
designed Snorbozyme (Small 
nucleolar RNA:ribozymes) 
Samarsky et al. (1999) 
Hepatitis B viral X mRNA 
(X-lacZ fusion gene) 
Cis-hammerhead ribozymes Yim et al.(2000) 
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Despite all the experiments carried out until now, the trans-cleavage in vivo has been 
difficult to be measured. There is no evidence so far that a trans-catalytic reaction proceeded 
to complete turnover in vivo. 
Ferbeyre and co-workers described the effect of cis- and trans-acting hammerhead 
ribozymes on ADE1 gene expression. The cis- and trans-acting ribozymes were directed 
against the previously tested target site for this gene which was insensitive to antisense RNAs 
(Ferbeyre et al., 1995). The ribozymes and mutant ribozymes (no catalytic activity) were 
transcribed under control of the GAL1 promoter from episomal expression plasmids. The cis-
acting ribozymes were able to cleave the RNA resulting in the expected phenotype of 
reduction on the ADE1 expression; however, trans-acting ribozymes did not show any effect 
on the ADE1 expression. They concluded that the catalytic activity in vivo could easily be 10-
100-fold slower than in vitro; the secondary structure in vivo is complex and binds proteins, 
and the ribozymes must diffuse to the site of action. The trans-cleavage activity would not be 
as successful in rapidly growing yeast cells as in mammalian cells due to their markedly faster 
cell cycle and faster RNA metabolism. These problems were eliminated in further studies by 
arresting yeast cells in the G1-phase of the cell cycle. In those cells, trans-cleavage by 
hammerhead ribozymes on ADE1 mRNA was observed (Ferbeyre et al., 1996). 
 
In order to explain the lack of trans-cleavage activity in yeast, further analyses suggested 
that S. cerevisiae cells have an immanent inhibition-activity, that affects hammerhead 
ribozymes mediated trans-cleavage. Yeast splicing extracts added to an in vitro cleavage 
reaction inhibited the cleavage activity; this observation has not been found in mammalian 
extracts (Castanotto et al., 1998). However, whether this activity also influences the in vivo 
trans-cleavage activity is not clear until now. 
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The reduction of the expression level in the presence of ribozymes has been difficult to 
point out if the reduction is due to a cleavage activity rather than an antisense mechanism. In a 
more recent communication, it was reported that hammerhead ribozymes induce a 
translational suppression rather than cleavage activity in S. cerevisiae, although the cleavage 
of the target was detected by primer extension assays. Inactive variants of hammerhead 
ribozymes directed against the same target were found to suppress the expression in vivo 
(Yim et al., 2000). 
 
 
The information reveals that the key requirements to be considered in order to have an 
efficient cleavage activity involve: 
1.  Unlimited intracellular concentration of ribozymes which requires a robust 
transcription rate or good metabolic stability of the ribozymes. 
2. High degree of co-localization of the ribozyme in the same compartment(s) as the 
target molecule. 
3. Highly productive ribozyme-target interaction, i.e. good accessibility to the 
relevant RNA sequences of the catalytic and substrate molecules. 
Effective trans-acting ribozymes have been described that allow near perfect cleavage in 
vivo when these critical facts were considered (Samarsky et al., 1999). Small nucleolar RNAs 
were used as both catalytic and target molecules. In this approach, hammerhead ribozymes 
were localized to the yeast nucleolus by using the U3 small nucleolar RNA as a carrier. The 
hybrid molecules cleave the U3 RNA with a nearly 100% efficiency in vivo. These results 
pointed out that the use of trans-acting hammerhead ribozymes is a feasible strategy to reduce 
the gene expression in vivo when stability, co-localization and accessibility of the relevant 
regions in the cleavage reaction is ensured. 
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1.3.1 Development of vectors 
 
Hammerhead ribozymes can be expressed endogenously from expression vectors 
containing the ribozymes gene. The selection of an appropriate cassette for intracellular gene 
expression is an important step in obtaining active ribozymes in the cell. Following the 
requirements mentioned above, the use of (i) promoters for high level expression, (ii) specific 
termination sequences, and (iii) sequences to increase the stability of the transcript or to 
facilitate selection of the transformants in cases of stable expression must be considered 
(Amarzguioui & Prydz, 1998). 
 
 
1.3.2 Expression Vectors 
 
Strong promoters to drive ribozymes expression such as pol II and pol III promoters have 
been tested. For pol II promoters, the addition of a 5’cap and a 3’poly (a) tail should increase 
the stability and should influence the cytoplasmic localization. However, this implies the need 
for very long upstream and downstream sequences in order to have a high level of 
transcription. The short ribozyme sequence is embedded between long untranslated regions 
which might influence the formation of the catalytic active structure. Expressing ribozymes 
from pol III cassettes leads to high intracellular levels of the ribozymes. This expression can 
localize the ribozymes either in the nucleus or in the cytoplasm, depending on the pol III 
system used. Good and Engelke (1994) have created a special system, to promote the 
accumulation of transcripts under the control of intragenic promoters for SUP4 tRNA and 
RNase P (RPR1) genes on episomal plasmid derived from the Sikorski and Hieter pRS vector 
series (Sikorski & Hieter, 1989). The SUP4 tRNA gene intragenic promoter was tested to 
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express an RNA consisting of the full tRNA primary transcript attached to the ribozymes. 
Normally in yeast, dimeric tRNA genes have their promoter in a coding region of the first 
gene in the pair. This first construct does not have the sequences needed for processing the 
tRNA and remains bonded to the following RNA. This leads to a stabilizing effect preventing 
a 5’-3’ exonucleolytic attack. Such an approach has been used with enormous success in 
mammalian cells (Castanotto et al., 1999, Amarzguioui & Prydz, 1998). The second 
intragenic promoter analyzed was the promoter of RNase P RNA gene. Ribozymes were 
fused to the leader of this promoter. The corresponding RNAs were not recognized by the 
RNase P maturation process resulting in a high and stable accumulation of the transcripts. A 
high degree of ribozyme expression could be observed depending on the copy number of the 
plasmid used and the RNA expressed (Good & Engelke, 1994). 
 
In a further analysis, a comparison was made between a novel system that was constructed 
from regulatory elements present in the pol I promoter and the enhancer/ termination of rDNA 
with the pol II-and pol III-dependent system to express hammerhead ribozymes (Blancafort et 
al., 1997). The pol I vector contained the ribosomal promoter, the enhancer/termination region 
of the ribosomal RNA transcription and the yeast URA3 gene. The pol II plasmid was 
constructed by inserting the hammerhead ribozyme gene between the inducible galactose 
promoter and the ADH1 terminator. The pol III plasmid pIIIEx426 was chosen from the Good 
and Engelke plasmid series (described above) and a hammerhead ribozyme sequence was 
inserted between the RPR1 promoter and the terminator. The pol III system gave the highest 
RNA expression levels while expression with the pol I system was only detectable when some 
modifications where made in order to extend the distance between promoter and enhancer. 
Thus, the RNA expression of pol I reached a level similar to the level of the pol II expression. 
Moreover, the expression obtained with the pol I system depends on the composition of the 
medium and the growth rate. Both factors regulate the number of active transcription units. 
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1.3.3 Co-localization 
 
It is well known that the co-localization of ribozymes with the target RNA improves the 
efficiency of the hammerhead catalysis. However, it is not clear yet which are the 
mechanisms that control the transport of RNAs from the transcription site to the translation 
site. It has been described that some nuclear transcripts are processed and delivered along 
specific routes and the transcripts are distributed in specific positions on the nucleus 
(Brodsky, A. S. & Silver; P. A., 2000). Co-localization strategies could take advantage of 
various post-transcriptional processing events that take place in the nucleus of the cell. Beach 
et al. (1999) described that the 3’ untranslated regions of some RNAs may carry signals that 
are responsible for their localization in the cell. These signals can be used to direct ribozymes 
to specific locations. Samarski and co-workers (1999) used the small nucleolar RNA as 
carrier of ribozymes to the yeast nucleolus. The hammerhead ribozymes were delivered as 
hybrid molecules to the expected sub-cellular target location place. The cleavage activity 
observed has been the most efficient result reported up to now. This can be beneficial for 
decreasing the expression of some nucleolus associated RNAs. 
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1.4 Metabolic engineering 
 
For several centuries S. cerevisiae has been used in the production of food and alcoholic 
beverages, and today it is also used in different processes within the pharmaceutical industry. 
S. cerevisiae is classified as a GRAS organism, i.e. generally regarded as a safe organism, is 
non-pathogenic and can be added in consumable products. Genetic modifications by 
recombinant DNA technology in S. cerevisiae have enabled the manipulation of a given 
pathway of interest in order to facilitate the production of a particular metabolite. 
Metabolic engineering has been defined as improvements to the cellular properties 
achieved from the interplay of theoretical analysis relying on biochemical information and 
application of genetic engineering. The analytical side deals with the analysis of the cells in 
order to identify the most promising targets. Genetic engineering of cells basically consists of 
genetic modifications that are made for producing a certain cell construct. The synthesis part 
of the metabolic engineering must consider the limiting factors of the analytical part. These 
factors depend on the complexity of the cellular metabolism. It is possible that metabolite 
levels may interact with gene expression or the gene expression might determine the 
metabolite levels via enzyme concentrations. In cases where many modifications are made, 
each modification implies unexpected changes in the cellular metabolism (Ostergaard et al., 
2000). 
The applications of metabolic engineering in S. cerevisiae are divided in four categories; 
(i) extension of substrate range, (ii) improvements of productivity and yield, (iii) elimination 
of by-products, and (iv) improvements of cellular properties and extension of product range 
including heterologous protein production. 
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 In the area of yield and productivity improvement, the pathway analysis often describes 
the application of metabolic flux analysis and metabolic control analysis. The concept of 
metabolite balancing can be explained using a simple pathway where a product A is converted 
to product B with the formation of a by-product C (Fig. 5). The overall yield of product from 
the substrate is given by the ratio of the fluxes JB and JA, and the productivity is given by the 
flux JB. 
 
 
 
Figure 5: Schematic representation of a metabolic network illustrating the fluxes JA, JB 
and JC around the intermediate I, that is the precursor of metabolite B and C. 
 
The intermediate I does not accumulate in the cell and the flux into this metabolite will 
therefore equal the flux out of the metabolite pool. The fluxes are constrained as (JA = JB + JC), 
and one flux can be calculated when the others are measured (Ostergaard et al., 2000). 
Therefore, in order to improve the productivity of one product, B for example, it is clear that 
the other flux must be reduced or eliminated. However the formation of C could play an 
important role in the metabolism, and its elimination will be lethal or lead to auxotrophy. Here 
the use of trans-acting hammerhead ribozymes might be a promising strategy in metabolic 
engineering. Using this technique, it should be possible to induce an increment of a specific 
 31 
metabolite by reducing the expression of a specific gene without disturbing or destroying the 
viability (and/or vitality) of the organism. This is an important advantage over other 
approaches such as the use of antisense nucleic acids or gene disruption which may affect the 
viability of the cells. Therefore, the trans-acting ribozyme technology will enable the 
identification of enzymes that exert flux control in a given metabolic pathway as well as 
possibly contributing to information about regulation of different fluxes in “sensitive” routes. 
 
 
1.5 Concluding remarks 
 
The hammerhead ribozyme belongs to the most attractive tools for reducing gene 
expression. Its simple structure and design, as well as its specific properties and broad 
application range, makes this small catalytic RNA useful for studying cellular pathways in 
different systems. It has not been clear until now which is the intermolecular mechanism that 
mediates the cleavage reaction. However, the catalytic process mediated by hammerhead 
ribozymes has been widely used. The design of ribozymes and the selection of appropriate 
targets have been the aim of many investigations during the last few years. The elaboration of 
model systems for simple ribozyme delivery to have an efficient reduction of the gene 
expression is important to establish the prerequisites needed for the ribozyme cleavage 
activity. For investigating metabolic pathways in S. cerevisiae, the ribozyme technology is 
promising when it is applied to the manipulation of target genes that are essential for vitality 
or viability. However, the data published until now reveals the absence of information about 
the factors involved in catalytic activity in vivo. Moreover, many vectors for ribozyme 
expression in yeast have been described but were successful only in a few cases. The 
localization and expression levels of ribozyme are important factors to be considered. 
 32 
 
2 Subject description 
 
The importance of glycerol for synthesis of many products ranging from cosmetics to 
lubricants has attracted increasing attention during the last few years. The annual production 
of ca. 600,000 tons is mainly recovered as a by-product of soap manufacturing or it is 
produced from propylene. However, glycerol can also be produced by microbial fermentation 
and the investigation into this route has been pursued at mostly in yeast cells (Overkamp et 
al., 2002). Glycerol is involved in carbon metabolism of Saccharomyces cerevisiae in 
different ways. It can be utilized as a sole carbon source under aerobic conditions and it is 
formed as a major by-product when S. cerevisiae ferments sugar to ethanol via a redox-neutral 
process. Glycerol is formed by the reduction of dihydroxiacetone phosphate (DHAP) to 
glycerol-3-phosphate, concomitant with a NADH oxidation by NAD+-dependent 3-phosphate 
dehydrogenase. Then glycerol-3-phosphate is dephosphorylated to glycerol by glycerol-3-
phosphatase (Fig. 6). The synthesis of glycerol seems to play an important role in maintaining 
the cytosolic redox state under anaerobic and glucose repression conditions as well as 
functioning as osmolite for enabling yeast to grow in high osmolarity (Overkamp et al., 2002; 
Cronwright et al., 2002; Nevoigt & Stahl, 1997). 
Furthermore, glycerol-3-phosphate, the intermediate in the glycerol formation 
pathway, is a key metabolite for the synthesis of lipids; therefore, the optimization of its 
production is an interesting biotechnological goal. The development of strains that produce 
larger-than-normal amounts of glycerol-3-phosphate has received major attention (Nevoigt & 
Stahl, 1997). 
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Figure 6: Schematic representation of the glycolytic pathway. Genes of products which are 
involved in this cellular process are given next to the arrows. In the glycerol flux, 
dihydroxiacetone-phosphate (DHAP) is detoxified by its reduction to glycerol-3-phosphate 
(Glycerol-3-P) and subsequent dephosphorylation to glycerol. Abbreviations: FBA: Fructose-
1,6-bisphosphate aldolase gene, TPI: Triose phosphate isomerase gene, GPDH: 
Glyceraldehyde-3-phosphate dehydrogenase gene, PGK1: Phosphoglycerate kinase gene, 
PGM: Phosphoglycerate mutase gene, PYK: Pyruvate kinase gene, PDC: Pyruvate 
decarboxylase gene, ADH: Alcohol dehydrogenase gene, GA3P: Glyceraldehyde-3-
phosphate, 1,3-BPG: 1,3-Biphosphoglycerate, 3-PG: 3-Phopshoglycerate, 2-PG: 2-
Phosphoglycerate.  
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2.1 Aim of this thesis 
 
 The aim of this thesis is to apply hammerhead ribozymes in S. cerevisiae to reduce the 
expression of a gene encoding glycolytic enzyme in order to influence the metabolic pathway 
of glycerol. This creates an influence on the glycolytic fluxes which ideally should lead to a 
decrease in the ethanol production and improve the glycerol-3-phophate yield. 
The glycolytic gene chosen as target for effective trans-acting hammerhead ribozyme 
application should have the following characteristics: 
 
i) No available isoenzymes. This is important since a reduction on the gene 
expression might be by-passed with enzymes and no effect could be observed. 
ii) Known knock-out and over-expressed phenotype. The knowledge of both types 
can be an aid in determining the real influence on the glycolysis. 
iii) High copy number and slow turnover transcript. Thus, the detection of the 
cleavage products will be enhanced and the ribozyme activity can be confirmed. 
 
The information for glycolytic genes available as targets is listed below (Table 2). This 
was obtained from the Saccharomyces Genome Database published in the internet 
(http://genome-www4.stanford.edu/Saccharomyces/SGD/) and RNA decay data was obtained 
from Precision and functional specificity in RNA-decay available at the web site: http://www-
genome.stanford.edu/turnover/index.shtml). 
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Table 2: Characteristic of glycolytic gene products. 
Enzyme Associated gene null mutant mRNA 
copies/cella 
mRNA half life 
(min) 
Triose phosphate 
isomerase  
TPI1 inviable n.a. 32 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
TDH1 
TDH2 
TDH3 
viable 
viable 
viable 
 
425TDH2/TDH3 
 
55 
49 
59 
Phosphoglycerate 
kinase 
PGK1 inviable in 
glucose media 
139 70; 40b 
Phosphoglycerate 
mutase  
GPM1 
GPM2 
GPM3 
inviable 
viable 
viable 
168 67 
71 
11. 
Enolase  ENO1 
ENO2 
ERR1 (homolog) 
viable 
inviable 
unknown 
 
229 
39 
51 
Pyruvate kinase PYK1 
PYK2 
inviable 
viable 
69 67b 
a. Published by Velculescu et al., 1997. 
b. Published by Moore et al., 1991. 
n.a. not available. 
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The phosphoglycerate kinase 1 gene (PGK1) seems to be adequate as a target; its 
transcript has high stability and slow turnover. Hence, it should provide abundant substrate for 
detecting ribozyme-mediated cleavage. Furthermore, its knock-out phenotype is known, i.e. 
pgk1 knock-out is inviable in media with glucose as carbon source. This strain can only grow 
on non-fermentative carbon sources and no isozymes have been identified. Thus, alterations 
on the PGK1 gene expression directly affect the glycolysis and there is no other enzyme 
involved in this metabolic process that can fulfil the role of PGK1. Only one copy of the 
PGK1 gene is found in the haploid cell. The primary sequence, open reading frame and 
information about the flanking regions are available (Hitzeman et al., 1982; Holland & 
Holland, 1978). The PGK1 promoter yields a high level of expression and is regulated in 
response to a carbon source. It is highly expressed in glucose but less well expressed in yeast 
cells grown in carbon sources such as pyruvate and acetate. It has furthermore been employed 
in yeast expression vectors for high expression of heterologous genes (Holland & Holland, 
1978; Piper et al., 1988a; Piper et al., 1988b; Chambers et al., 1989). 
Phosphoglycerate kinase (Pgk1) catalyses a reversible reaction, by transferring a 
phosphoryl group of 1,3-diphosphoglycerate to ADP to give 3–phosphoglycerate and ATP 
(Fig. 6). Ciriacy and Breitenbach (1979) showed that a block of the glycolytic pathway at the 
level of PGK1 induces an accumulation of dihydroxiacetone-phosphate (DHAP). DHAP is an 
important intermediate for glycerol production and revealed a positive influence on the 
glycerol flux. 
Reduction in the PGK1 expression should induce an increment of the production of 
glycerol-3-phosphate (G-3-P). Thus the subject of this work is the design of a model system 
to decrease the expression of the PGK1 gene encoding the phosphoglycerate kinase of the 
glycolytic pathway by trans-acting hammerhead ribozymes, in order to get an increment 
of the G-3-P production and to observe the effects on the glycolytic pathway. 
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This project is a new approach in the study of the ribozyme expression in yeast to identify 
the factors to be considered for the creation of a system to deliver ribozymes in yeast. 
Moreover, the improvement of the glycerol-3-phosphate yield is biotechnologically important 
for industrial purposes in the phospholipids synthesis market. 
 
A trans-ribozyme activity in yeast has only been documented in a few cases. It is well 
known that an efficient trans-cleavage reaction depends on an unlimited intracellular 
concentration of the ribozyme, as well as a high degree of co-localization and efficient 
interaction of the ribozyme with the target molecule. Therefore, this project starts with the 
identification of possible targets on the PGK1 RNA by computer programs that might be 
useful for designing asymmetrical hammerhead ribozymes. Constructed PGK1/ribozyme 
expressing plasmids containing a pol III promoter should lead to a high concentration of the 
ribozyme and co-localization with its target mRNA. The ribozyme delivery is tested through 
three different systems and a pgk1 knock-out strain is created. The cleavage activity is 
investigated in vitro and in vivo. In vitro activity of the ribozymes is tested by cleavage 
reaction and in vivo activity is determined by northern blot and primer extension. The 
influence on the PGK1 expression is analyzed by measurements on the PGK1 activity and 
glycerol production. 
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3 Material and Methods 
 
 
3.1 Materials 
 
 
3.1.1 Equipment 
 
Autoclave 1651; Fedegari, Italia 
Balances Type 1907 and 2462; Sartorius, Goettingen 
Centrifuges Sorvall RC-5B; Dupont, Bad Homburg; Microrapid; 
Hettich, Tuttlingen  
Clean bench uvub 1200 Uniflow 
Electrophoresis chambers Bio-Rad 
Geiger-Mueller counter Bertold LB 1210 C; Wildbald 
Incubators Biometra OV1; Biometra, Goettingen 
Micromanipulator MSM System, Singer instruments 
Microscope Leitz, Wetzlar 
PCR equipment T Gradient Whatman; Biometra, Goettingen 
Photographic equipment Olympus OM-2 with 50 mm objective; Dunco, Berlin; 
INTAS 
Pipetting equipment P10, P20, P200, P 1000; Abimed 
Power suppliers Phero-Stab 500; Biotec Fischer, Reiskirchen 
Rotors GSA, SS34; Dupont, Bad Homburg 
Spectrophotometer Uvikon 860; Kontron Instruments 
Transilluminator INTAS; Goettingen 
Vacuum equipment Rotary Slide pump; Heraus, Hanau 
Cooler; Uni-Equip, Matinsried 
Centrifuge Speed-Vac; Savant, Hickville 
UV Crosslinker UV Stratalinker™ 1800; Stratagene, La Jolla, USA 
Water baths Grant LTD; Thermomix 1460 Braun, Melsungen 
“thermed” 5001; GFL, Burgwedel 
X-ray cassettes Kodak X-Omatic with intensifying screen; Kodak, Berlin 
 
 
3.1.2 Enzymes, chemicals and kits 
 
Manufacturer, Location Product (s) 
Amersham, Buchler Hybond N+ membranes, Multiprime DNA-Labelling Kit 
BIOMOL, Hamburg Ampiciline, IPTG, X-Gal, Phenol 
Boehringer, Mannheim dNTP’s, DTT, λDNA size marker, restriction enzymes 
Qiagen, Duesseldorf Qiagen midi/maxi plasmid preparation kit, Oligotex mRNA 
kit 
Fluka, Neu-Ulm APS, Cellulose, Urea 
Fuji, Japan X-ray films NewRX  
Greiner, Nuertingen Eppendorf tubes, pipettes tips, petri dishes 
ICN Biomedicals Inc., Ohio Lytic enzyme, Glyceraldehyde phosphate dehydrogenase 
Kodak, Berlin X-ray development solution 
MBI Fermentas, St.Leon-Rot Taq polymerase, RNA ladder low range, M-MuL V 
Reverse Transcriptase 
Merck, Darmstadt Acetic acid, ethidium bromide, HCl, KCl, β-
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mercaptoethanol, MgCl2, MgSO4·7H2O, NaCl, potassium 
acetate, Rnase A, sodium acetate, ZnCl2, PEG 4000 
Millipore, Eschborn Microdialysis membranes (0,025µm) 
New England Biolabs, 
Schwalbach 
Restriction enzymes 
Oxoid, Hampshire Peptone 
Pharmacia, Freiburg Agarose NA, restriction enzymes 
Promega pGEM-T and pGEM-T Easy kit 
Roth, Karlsruhe Isopropanol 
Serva, Heidelberg Glucose, EDTA, SDS, TEMED, MOPS, Agar-Agar 
Sigma Deisenhofen Tris, Triton X-100, 3-Phosphoglycerate, ATP, β-
Glucuronidase  
Stratagene Restriction enzymes 
 
Most all the chemicals used in this study were listed above otherwise were obtained 
from Merck, Serva, Sigma, Pharmacia with analytical grade or even better quality. 
 
 
3.1.3 Strains 
 
Escherichia coli NM522 supE thi-1 ∆(lac-proAB) ∆(mcrB-hsdSM)5 (rK- mK+) 
[F'proABZ∆M15] supplied by Amersham Pharmacia 
Biotech Europe, Freiburg. 
Saccharomyces cerevisiae CEY 
1118-6B 
MAT α, his3∆1, leu2∆0, lys2∆0, ura3∆1  
Saccharomyces cerevisiae CEY 
1123-6D 
MAT a, his3∆1, trp1∆63, ura3∆1 
Saccharomyces cerevisiae 
diploid strain CEY  
This strain was obtained by crossing the spore clones CEY 
1118-6B and CEY 1123-6D which were kindly provided by 
Charles B. Epstein (University of Texas, SWMC at Dallas, 
TX, USA) 
 
 
3.1.4 Plasmids 
 
pGEM-T Linear plasmid containing E.coli lac Z gene (Promega) 
pGEM-T Easy Linear plasmid containing E.coli lac Z gene (Promega) 
pRS416 Low copy yeast shuttle vector derivative from pRS vectors 
series created by Sikorski and Hieter (Sikorshi & Hieter, 
1989) containing CEN6/ARS and URA3 gene (Stratagene, 
La Jolla, CA, USA) 
pIIIEx423 RPR High copy yeast shuttle vector developed by Good and 
Engelke (Good & Engelke, 1994) derivative from Sikorski 
and Hieter plasmid vectors, containing 2µ ori, His3 gene, 
RPR1 intragenic promoter and RPR1 poly (T) terminator. 
This vector was kindly provided by D.R. Engelke 
(University of Michigan, Ann Arbor, MI,USA) 
pUG6 Derivative from pFA6-kanMX4 containing the loxP-
kanMX-loP disruption cassette (Gueldener et al., 1996) 
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3.1.5 Oligonucleotides 
 
 All the oligonucleotides used in this study were synthesized by Metabion (Berlin). 
 
 
Oligonucleotides Sequence 
 For PGK1 disruption 
 
KO5 5’-GTT GCT GCT TTG CCA ACC ATC AAG TAC GTT 
TTG GAA CAC C-3’ 
KO3 5’-CTT CTT AGC GAC AGT GGC AGT GTC ACC ACC 
ACC AAT GAT GGC ATA GGC CAC TAG TGG ATC 
TG-3’ 
 
 For PGK1 cloning and checking of PGK1 disruption 
 
Pgk1-3 5’-CAT TTG CAT TGA ACG TCA TTA CAC-3’ 
Pgk1-4 5’-CAA GTG GGA TGA GCT TGG AGC-3’ 
Pgk1-5 5’-CAT CAC AGC AGT CAA TG-3’ 
3’UTR stp 5’-CGG AAT TCC GGC TTT CTT ATC CGA AAA GAA 
ATA A-3’ 
3’UTR ter 5’-CAT CCG CTC GAG CGG TCC AAG CTT ACA CAA 
CAC-3’ 
G1 5’-ACT GGC AAA GCT TCA CC-3’ 
G2 5’-TCA CTC GCA TCA ACC CA-3’ 
 
 For probes generation via PCR  
 
Pgk1-6 5’-CAG TGT TTT CCA AAA CCT TCT TG -3’ 
Pgk1-7 5’-CAT CAA GTA CGT TTT GGA ACA CC-3’ 
Actin-1a 5’-GAT AAC AGA TCT GGT ATG TGT AAA GCC-3’ 
Actin-1e 5’-CAC TCA AGA TCT TCA TCA AGT AGT C-3’ 
 
 For probe generation via polynucleotide kinase reaction 
 
Pgk1-0 5’-CAT TTT TCA TCT  ATT AAT AG-3’ 
 
 For probes generation via PCR used in PGK1 in vitro 
transcription  
 
Pgk1-8 5’-AGT GAG AAG CCA AGA CAA CGT -3’ 
Pgk1-9 5’-ACC TTC TTC TTC GAT GTG GTA -3’ 
Pgk1 tsp 5’-TAA TAC GAC TCA CTA TAG GGA GAA GTA ATT 
ATC TAC TTT TTA C-3’ 
 
 For cloning of Hammerhead ribozymes 
 
Rz 1 8/7 w GUC 5’-AAT TAG ATA AAC TGA TGA GTC CGT GAG 
GAC GAA ACA TTG TTG-3’ 
 
Rz1 8/7 c GUC 5’-AAT TCA ACA ATG TTT CGT CCT CAC GGA CTC 
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ATC AGT TTA TCT-3’ 
Rz 5 w GUC 5’-AAT TTC CAA TGG CTG ATG AGT CCG TGA GGA 
CGA AAC GTT GAA G-3’ 
Rz 5 c GUC 5’-AAT TCT TCA ACG TTT CGT CCT CAC GGA CTC 
ATC AGC CAT TGG A-3’ 
Rz 9 w GUC 5’-AAT TAA GCC TTC TGA TGA GTC CGT GAG GAC 
GAA ACA GCG GCG-3’ 
Rz 9 c GUC 5’-AAT TCG CCG CTG TTT CGT CCT CAC GGA CTC 
ATC AGA AGG CTT-3’ 
Rz 1 11//10 w GUC 5’-AAT TTG AAG ATA AAC TGA TGA GTC CGT 
GAG GAC GAA ACA TTG TTT TAG-3’ 
Rz1 11/10 c GUC 5’-AAT TCT AAA ACA ATG TTT CGT CCT CAC GGA 
CTC ATC AGT TTA TCT TCA-3’ 
Rz 14//13 w GUC 5’-AAT TTC TTT GAA GAT AAA CTG ATG AGT CCG 
TGA GGA CGA AAC ATT GTT TTA TAT G-3’ 
Rz1 14/13 c GUC 5’-AAT TCA TAT AAA ACA ATG TTT CGT CCT CAC 
GGA CTC ATC AGT TTA TCT TCA AAG A-3’ 
 
 For ribozyme in vitro transcription  
 
RPR1 tsp 5’-TAA TAC GAC TCA CTA TAG GGA GAG TTT TAC 
GTT TGA GGC C-3’ 
RPR1 ter 5’-AAA AAG AAA GAT TAA ATT GGA-3’ 
 
 For sequencing 
 
RPR1-1 5’-GTG TAT TCT TCC TGC TCC AAG C-3’ 
rpr1# 1 5’-GTC AAC AGG ATA TGT TA-3’ 
Pgk1-10 5’-GAA ATA AAT TGA ATT GAA TTG-3’ 
 
 For Reverse Transcription 
 
Pgk1-11 5’-AAT TCC TTA GCA ACT GGA GCC AAA GAG 
TAT-3’ 
 
 
3.1.6 Media, buffers and solutions 
 
Media  
Escherichia coli  
LB 1 % Tryton; 0,5 % yeast extract; 1 % NaCl  
LB +Amp LB + 100 µg/ml Ampicilline 
LB +Amp+IPTG/XGal To 500 ml LB + Amp were added 5 ml 100mM IPTG and 
600 µl X-Gal (40.85 mg/ml) 
 (Solid medium was prepared by adding 1,5 % Agar-agar) 
Saccharomyces cerevisiae  
YE 2 % Glucose; 0.5 % Yeast extract; pH 6,3 
YEGE 2 % Glycerol; 2 % Ethanol; 0.5 % Yeast extract 
YE + G418 YE + 50-200 µg/ml G418 
YEGE + G418 YEGE + 50-200 µg/ml G418 
YEPD 2 % Glucose; 2 % Peptone; 0.5 % Yeast extract; pH 6.3 
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YNB 0.67 % Yeast Nitrogene Base w/o Aminoacids (DIFCO), 2 
% Glucose, 40 mg/L aminoacids (depending on the strain 
used) 
Presporulation 10 % Glucose, 0.8 % Yeast extract; 0.3 % Peptone  
Sporulation 0.05 % Glucose,1 % Potassium acetate; 0.1 % Yeast extract 
 (Solid medium was prepared by adding 1.5 % Agar-agar) 
 
 
 
Buffers  
PBS 10 mM NaPO4; 150 mM NaCl 
1M Phosphate buffer  1 M Na2HPO4; 1M NaH2PO4 adjusted to pH7.0 
20 x SSC 3 M NaCl; 0.3 Na3-citrat; pH 7.0 
TAE 2 mM EDTA; 20 mM Na-acetate; 40 mM Tris; pH 8.3 with 
Acetic acid 
TBE 9 mM Tris; 9 mM Boracic acid; 0.25 mM EDTA; pH 8.2 – 
8.4 
 
TE 10 mM Tris;1 mM EDTA; pH 8.0 
  
Solutions  
Denaturating PAA (5%) 8M Urea; 5% PAA; 1 x TBE 
DEPC – H2O 0.1% DEPC 
Ethidium Bromide 10 mg / ml Ethidium Bromide 
MgCl2 – Tris-HCl 10 mM Tris;100 mM MgCl2 6H2O; pH 7.6 
CaCl2 – Tris-HCl 
 
10 mM Tris;100 mM CaCl2 6H2O; pH 7.6 
8 % PEG Solution 
 
8% PEG2000 ;1 mM EDTA; 0.2 M NaCl;10 mM Tris HCl; 
pH 7.6  
 
 
3.1.7 Cultivation conditions 
 
Escherichia coli 
 
E. coli strains were cultivated in LB medium at 37°C. Recombinant clones were selected in 
LB plates supplied with 100µg/ml Ampicilline or were identified by blue-white screening on 
indicator plates (IPTG; X-Gal). 
 
Saccharomyces cerevisiae 
 
Wild type S. cerevisiae strains were grown in YEPD plates at 28°C. Transformants were 
grown in YNB or in YE + G418 medium. For pre-cultures a medium size yeast colony was 
picked and transferred to 50 ml medium and grew at 28°C overnight. The selection of the 
medium inoculated depended on the strain. 
 
Aerobic cultures. 100 ml shake-flask cultures were inoculated with 0.1-1 % of pre-cultures 
and grown at 28°C on an orbital shaker at 160 rpm for 24-48 hours. 
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Anaerobic cultures. The batch fermentations were performed in 100 ml Erlenmeyer flasks 
containing YNB medium supplied with the appropriate aminoacids for each strain. The 
cultures were stirred continuously at 300 rpm after closing the vessels with air locks, which 
ensured the exclusion of oxygen allowing the release of gases. 
 
 
3.2 DNA and RNA isolation 
 
 
3.2.1 Isolation of plasmid DNA from E.coli strains 
 
Plasmid DNA was isolated from 1 ml of overnight cultures according to “miniprep” 
method developed by Ish-Horowicz and Burke for analysis of transformants (Ish-Horowicz & 
Burke, 1981). Large-scale plasmids isolations from 50-100 ml cultures were performed 
according to the manual of the Qiagen Pack-100/500 purification kit. The DNA concentration 
was determined by spectrophotometry (Sambrook et al., 1989). 
 
3.2.2 Isolation of genomic DNA from S. cerevisiae strains 
 
10 ml YEPD were inoculated and the cells were grown overnight at 28°C. The cells 
were harvested at 8K rpm for 3 min, resuspended in 0.5 ml distilled water, and transferred to 
an Eppi tube. The cells were newly harvested at 10K rpm for 3 min and resuspended in 200 µl 
lysis buffer (2 % Triton –100, 1 % SDS, 100 mM NaCl, 1 mM EDTA, 10 mM Tris-Hcl; pH 
8.0). 0.3 g of glass beads (0.45-0.5 mm dia), 100 µl Phenol and 100 µl Chloroform/ 
Isoamylalcohol (24:1) were added and vigorously mixed for 3-4 min. After of that 600 µl TE 
was added and centrifuged at 10K rpm for 5 min. The aqueous phase was recovered and 
transferred to a fresh tube with 1 ml of ethanol and centrifuged at 10K rpm for 10 min at 4°C. 
The supernatant was discarded and the pellet was resuspended in 400 µl TE containing 3 µl of 
RNAse A (10 mg /ml) and incubated at 37 degrees for 5 min. After incubation 10 µl 5 M 
ammonium acetate were added and the nucleic acids were precipitated by adding ethanol and 
centrifugation at 10K rpm for 10 min at 4°C. The recovered pellet was washed with 70 % 
ethanol, dried at room temperature and finally gently resuspended in 50 µl TE.  
 
3.2.3 Isolation of plasmid DNA from S. cerevisiae 
 
 Colony was picked and transferred to 200 µl of lysis buffer for plasmid isolation (100 
mM NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, and 0.1 % SDS). Equal volume of glass 
beads (0.45 mm dia) were added and vortex at top speed for 1 min. The extraction was made 
one time with 200 µl of phenol/CHCl3 (2/1). Plasmids were precipitated with ethanol, after of 
that washed with 80 % ethanol, dried for being resuspended in 100 µl TE and used to 
transform E. coli. 
 
3.2.4 Isolation of RNA from S. cerevisiae  
 
 YEPD (50 ml) overnight cultures were harvested at 3-5K rpm for 5 min at 4°C and put 
on ice. Cells were resuspended in 10 ml citrate buffer (1.2 M sorbit, 20 mM K2HPO4, 1 mM 
EDTA; pH 5.8), incubated with 1-5 mg/ml of Lytic enzyme (ISN) for 20-30 min at 37°C, and 
spun down at 5K rpm for 5 min at 4°C. Secondly, the cell were broken by suspending in 5 ml 
of denaturing solution (250g Guanidinthiocyanate, 293 ml DEPC-water, 24,6 ml 10% 
Sarkosyl, 17,6 ml 0,75 M sodium citrate, pH 7,0; heated at 65°C for diluting) and 5 ml of 
DEPC water, vortex for 1 min. Then 0.5 ml of 2M Na-acetate (pH 4,0), 5 ml phenol, and 1ml 
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CHCl3/Isoamylalcohol (24:1) were added, this solution was vortex vigorously for 10 sec and 
placed on ice for 15 min. After centrifugation at 10K rpm for 20 min at 4°C the aqueous 
phase was pulled off to a fresh tube and precipitated with 5 ml of Isopropanol at –20 °C 
overnight. On the next day, the nucleic acids were centrifuged at 10K rpm for 20 min at 4°C. 
The pellet was washed with 80 % Ethanol, spun down at 10K rpm for 5 min, dried in a Speed-
Vac as short as possible and dissolved in 300 µl of DEPC-water. 
 Additionally, 250 µl of total RNA isolation were used for poly (A)+ mRNA isolation 
using the Oligotex mRNA kit (Qiagen), the protocol was performed according to the manual 
described by the manufacturer. After isolation a volume of 20-30 µl of poly (A)+mRNAs was 
purified usually.  
 
3.2.5 Isolation of DNA from Agarose gels 
 
 DNA fragments were isolated from gels using the Jet-Sorb gel elution kit (Genomed). 
The method was accurately follow how was described by the manufacturer. The base of this 
method is the DNA absorption on a matrix and its subsequent extraction. The DNA samples 
were mixed with 10 µl/ml ethidium bromide before running on agarose gels, after run the 
DNA was identified with 354 nm UV light and the interesting band was cut out and purified 
with the chemicals supplied by the supplier. 
 
3.2.6 Isolation of labelled RNA from PAA gels 
 
 For purification after in vitro transcription, labelled RNAs were separated on 
polyacrylamide gels. Gels were autoradiographed immediately afterwards to detect the 
desired band, which was cut out and transferred to a 0.5 ml tube with 400 µl Elution buffer 
(0.5 M NH4OAC, 0.1 % SDS, 0.1 M EDTA; pH 8) and placed at 4°C overnight. The 
supernatant was transferred to a fresh tube with 800 µl ethanol and centrifuged at 10K rpm for 
20 min, the supernatant was discarded and the pellet was dissolved in 10 µl DEPC-water. 
 
 
3.3 DNA in vitro recombination methods: Restriction, dephosphorylation, and ligation 
 
 Restriction analyses were performed according to Sambrook et al. (1989), with 1-7 
Units enzyme per µg DNA. For dephosphorylation 1 unit of alkaline phosphatase (AP) was 
added. To inactivate the AP activity 2 µl EGTA were added and incubated at 65°C for 10 min, 
after of that the samples were ready for ligation. The DNA fragments were described as was 
described above by Jet-sorb Extraction method. The ligation reaction was carried out with 1 
µl Ligase for a total volume of 20 µl and incubated overnight at 14°C. 
 
 
3.4 General PCR Method 
 
 The reaction was performed in 20 µl volume in a 0,2 ml reaction tube and the 
following solutions were pipetted: 9.8 µl H20, 1,6 µl 2.5 mM dNTP’s (Boehringen, 
Mannheim), 5 µl 4x reaction buffer (MBI Fermentas, St. Leon-Rot), 1 µl 10 pmol from each 
primer, 1 µl DNA (1ng plasmid DNA or 100-200 ng genomic DNA), and 0,2 µl Taq 
polymerase (4 U/ µl; MBI Fermentas, St. Leon-Rot). 
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 The PCRs were carried out in TGradient Whatman (Biometra, Goettingen) equipment. 
In general the following program was used: pre-treatment at 94°C for 2 min, 25 or 30 cycles 
when the target was plasmid or genomic DNA respectively, followed of incubation for 30 sec 
at 56-64°C (annealing), 72°C for 15-120 sec (elongation) and 94°C (denaturation) for 15 sec. 
Post-treatment comprised end-elongation at 72°C for 5 min. The annealing temperature was 
calculated by the G/C rule as Tannealing =1.42(Σ nt + .ΣG/C) +22°C The elongation time 
depended on the fragment length, thus 15 sec were used for short fragments until 600 bp and 
for longer fragment the elongation time was estimated by the Taq polymerase activity, i.e., 40 
bases/sec are incorporated in the new synthesized strand. 
 
 
3.5 Gel Electrophoreses 
 
 DNA electrophoresis was carried out horizontally; the agarose percent (1.0-2.5 %) 
depended on the size of the fragment to be separated in TAE (160 bp to 9 Kbp). Midi and 
mini size of gels were used: 18 x 10 x 0.5 cm and 12 x 10 x 0.5 cm, respectively. Gels were 
run at 100 V for 1-1.5 hours. Generally, the size markers used were λ DNA digested with 
HindIII and GeneRuler™ (100 bp DNA Ladder Plus; MBI, St. Leon-Rot). 
 
 RNA electrophoresis was done horizontally in formaldehyde gels 1 % agarose. Midi 
and mini size of gels were used: 18 x 10 x 0.5 cm and 12 x 10 x 0.5 cm. The protocol was 
followed how it was described by Odgen and Adams (1987). Gels were run at 100 V for 1-4 
hours. Size marker used was RNA ladder, low range (MBI Fermentas, St. Leon-Rot). 
 Nucleic acids were detected by staining the agarose gels with ethidium bromide (1 µg/ 
ml) and UV light (254 nm). 
 
 Radiolabelled RNA was separated for purification and cleavage analysis through 
denaturing RNA gels, 3.5 or 5 % acrylamide with Bis-acrylamide at 19:1, respectively and 8 
M urea as denaturant (Sambrook et al., 1989). All the solutions were previously treated 
against Rnases using DEPC-water. The size of the gels was 16 x 14 x 0.5 cm. Gels were run 
at 40 mA for 1.5-2.5 hours. After run, the gels were embedded in 10% methanol, 10 % acetic 
acid for 20 min in order to fix the gels to Whatman 3 MM paper by drying at 80° C for 1 
hour. Gels were exposed in X-ray cassettes and frozen at –70 °C. 
 
 
3.6 Northern blot analyses 
 
 Northern blot analyses were performed according to Sambrook et al. (1989). After gel 
electrophoresis, the RNA was transferred to a Qiabrane Nylon membrane (Qiagen) using a 
Possiblot™ pressure blotter and UV crosslinked. Probes were labelled using [α-32P] dATP. 
Hybridization was performed with Rapid buffer according the protocol supplied by the 
manufacturers (Amersham). Membranes were put in X-ray cassettes and incubated at 70 ° C. 
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3.7 Transformation methods 
 
 
3.7.1 Transformation of E.coli 
 
 E. coli transformations were performed according the heat shock method developed by 
Himeno et al. (1984). Competent cells were obtained by CaCl2 treatment; these cells were 
directly used or stored at –70°C in 100 mM CaCl2, 15 % Glycerin. To 200 µl of fresh cells or 
240 µl of freeze competent cells, 100 µl of 8 % PEG2000 (8 % PEG2000, 1 mM EDTA, 0.2 M 
NaCl, 10 mM Tris-HCl pH 7.6) and 20 µl of DNA were added. Cells were gently mixed, 
placed on ice for 30 min and a heat shock was applied for 1 min at 42°C. Adding 1 ml of LB 
medium and the incubation at 37 °C for 90 min made the regeneration. Cells were plated on 
the appropriated selection agar. Transformation efficiencies were about 104-106 CFU/µg 
DNA. 
 
 
3.7.2 Transformation of S. cerevisiae 
 
 Transformation of S. cerevisiae was made according the lithium acetate/PEG method 
(Gietz & Woods, 2002). 20 ml YEPD was inoculated and the cells were grown overnight at 
28°C and 120 rpm. 100 ml YEPD shake-flask cultures were inoculated at different 
concentrations (0.01 %, 0.05 %, and 0.1 %). Cells were grown overnight until OD600= 0.5, 
harvested at 5K rpm for 5 min and washed with 10 ml 0.1 M Li-acetate (0.1 M lithium 
acetate, TE pH 8.0) and resuspended in 2 ml 0.1 M Li-acetate. The mixture of transformation 
was done with 100 µl cells, 5 µl DNA (1-5 µg), 5 µl salmon sperm DNA (10 mg/ml), and 600 
µl PEG (40 % PEG4000, 0.1 M lithium acetate, TE pH 8.0), gently mixed and incubated at 
42°C for 30 min. Cells were harvested at 5K rpm for 5 min and plated on selective medium at 
different dilutions (1:10, 1:100, and undiluted). For selection on YE + G418 the cells were 
regenerated in 5 ml YE for 3-4 hour after plating. 
 Fast method. A shorter form of the lithium acetate method was also used. A picked 
colony (3 mm dia) was transferred to 1 ml distilled water in a 0.5 ml tube and spun 5K rpm 
for 5 min. Pellets were washed in 1 ml 0.1 M Li-acetate and resuspended in 0.5 ml 0.1 M Li-
acetate. The next steps were performed as before, regarding that the transformation mixture 
was carried out with a higher concentration of DNA about 5-10 µg. 
 
 
3.8 Radioactive labelling of DNA 
 
Random primer labelling using [α-32P] dATP (Hartmann Analytic) was performed for 
generating hybridization probes of PCR products (Megaprime labeling kit, Amersham). 
Single stranded oligonucleotides were labelled with [γ-32P] d ATP (Hartmann Analytic) using 
T4 Polynucleotide Kinase (Biolabs) according to Sambrook et al. (1989). 
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3.9 Ribozyme cleavage activity 
 
 
3.9.1 In vitro transcription reaction by T7 polymerase 
 
 The reaction was carried out using eluted PCR product as templates.  
 
Non-radioactive in vitro transcription of Ribozymes. The mixture reaction was done with 4 µl 
4 x Transcription buffer (MBI Fermentas, St. Leon-Rot), 1 µl RNAsin (20 U/ µl; Promega), 1 
µl 2.5 mM rNTPs (Boehringer, Mannheim), 10 µl PCR product (1 µg/ µl), and 1 µl T7 
polymerase (20 U/µl; MBI Fermentas, St. Leon-Rot). The mixture was incubated at 37°C for 
2 hours, then 1 µl DNase I Rnase free (2 U/ µl; Pharmacia) was added and incubated at 37°C 
for 15 min. The volume of the mixture was pull up to 100 µl and mixed with 15 µl NH4-
acetate 7 M. The mixture was extracted with equal volume of phenol/CHCl3: Isoamylalcohol 
(24:1), the aqueous phase was carefully transferred to a fresh tube and precipitated with 2 
volume ethanol and centrifuged at 13K rpm for 25 min. Pellet was dried in a Speed-Vac as 
short as possible and dissolved in 20 µl DEPC-water.  
 
Radioactive in vitro transcription of PGK1. The transcription reaction was modified by adding 
1 µl [α-35S] UTP (Hartmann Analytic) to the mixture reaction and after incubation at 37°C for 
1 hour, immediately after the transcription products were separated on 3.5 % PAA 8 M urea 
gels (3.5) and purified (3.2.6). 
 
 
3.9.2 In vitro trans-cleavage reaction 
 
 PGK1 transcript (50 mM) was combined with increased ribozyme concentrations 
between 50-500 mM combined in 17 µl with 1 µl 1 M Tris-HCl pH 7.6, heated at 95°C for 1 
min, cooled to room temperature for 15 min. The initiation was made by adding 2 µl 0.1 M 
MgCl2 and the reactions were incubated at 37°C for 1hour and stopped with 1 volume of stop 
solution (95% formamide, 20 mM EDTA, 0.05% bromophenol, 0.05% xylene cyanol). The 
cleavage products were separated by 5 % PAA 8 M urea gels and the detection was made by 
Autoradiography (3.5). 
 
 
3.9.3 Primer extension 
 
 For first strand of cDNA synthesis, volumes between 3-9 µl of poly (A)+ mRNA 
isolations (0.5-1.5 µg; 3.2.4) were prepared in a sterile tube with 20 pmol of sequence specific 
primer Pgk1-11 (3.1.5) and pull up to 11 µl. Simultaneously, 0.5 µg of in vitro PGK1 
transcript and/or 9 µl of cleavage reaction (described above) were used as control. After 
incubation at 70°C for 5 min, the samples were placed on ice for 10 min. 4 µl 5X reaction 
buffer (MBI Fermentas, St. Leon-Rot), 2 µl 10 mM dNTP (Boehringer, Mannheim), 1 µl 
RNAsin (20 U/ µl; Promega), and 1 µl [α-35S] ATP (Hartmann Analytic) were added and pull 
up to 19 µl. The reaction mixtures were pre-incubated at 37ºC for 5 min, after that the reaction 
started by adding 1 µl of M-MuL V Reverse Transcriptase (40 U/ µl; MBI Fermentas, St. 
Leon-Rot) and incubated at 37ºC for 4 hours. Reactions were stopped by adding 10 µl of 
loading buffer and heating at 70ºC for 10 min. The extended products were separated by 8% 
PAA 8 M urea gels and the detection was made by autoradiography (3.5). 
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The size marker used was a mixture of chain-terminated fragments generated from a 
ddCTP sequencing reaction using the T7 Sequencing kit from USB Corporation (USB 
Corporation, Ohio) and following rigorously the provided protocol. The DNA template was a 
PCR fragment used for in vitro transcription of PGK1. The labelling was made by adding 1 µl 
[α-35S] ATP (Hartmann Analytic) to the sequencing reaction. 
 
 
3.10 Ribozyme DNA construction 
 
 For annealing of the sense and antisense ribozyme strands, the following mixture was 
used: 1 µl from each oligomer (10 ng/µl), 500 mM NaCl and 7 µl distilled water. This sample 
was heated up to 70°C and let to cold until room temperature. For phosphorylation, 2 µl of 
this sample was pipetted to a 1.5 ml tube with 10 mM ATP, 2 µl 10 x Polynucleotide kinase 
buffer (BioLabs), 2 µl Polynucleotide kinase (10 KU/ml); BioLabs) and 12 µl distilled water. 
The mixture was incubated at 37°C for 60 min and the phosphorylation activity was 
inactivated by incubation at 65°C for 10 min. After that the DNA oligomer duplexes were 
ready for cloning into the vectors. 
 
 
3.11 Sequence analysis of DNA  
 
 Sequencing was carried out at the Freie Universitaet Berlin (Dr. Martin Meixner): The 
sequencing primers were listed under point 3.1.5. 
 
 
3.12 Protein analyses and Glycerol determination 
 
 
3.12.1 Isolation of total protein from S. cerevisiae 
 
The strains were inoculated in 50 ml YNB pre-cultures and grown overnight (strains with 
slower growth were grown for 2 days) until OD600= 1.0-1.5. Samples of 200 µl – 400 µl were 
inoculated to 100 ml YNB and grew overnight until OD600= 0.6-0.7. The same volume of 
culture was transferred to two SS34 tubes (40 ml) per strain and centrifuged at 3K rpm during 
15 min. Liquid phases were taken off and maintained always in ice. The cells were washed 
with 6 ml PBS and centrifuged in 6 ml tubes at 3K rpm for 5 min at 4°C. The liquid phase 
was discarded, the cells were resuspended in 500 µl PBS, 1% Triton, 1 mM PMSF and the 
suspension was transferred to a 0.5 ml fresh tube. For breaking the cells, one volume of glass 
beads was added and vigorously vortexed 1 min for 5 times, the suspension was centrifuged at 
12K rpm during 15 min and the aqueous phase was carefully transferred to a fresh tube. 
 
 
3.12.2 Activity and protein concentration 
 
PGK1 activity. The method was performed according to Scopes, 1975. For PGK1 activity 
measuring 50 µl crude extracts (diluted 1/10 with PBS; twice for each sample), 850 µl PGK1 
activity buffer (stock buffer: 30 mM Triethanolamine, 10mM 3-phosphoglycerate, 50 mM 
KCl, 5 mM MgCl2, 0.2 mM EDTA to this were freshly added 0.2 mg/ml BSA, 20-40 µg/ ml 
Glyceraldehyde phosphate dehydrogenase (50-100 IU/mg) and 0.1 mM NADH) were mixed 
and placed previously in spectrophotometer at 30°C to measure undesired contamination. 
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Adding 100 µl 50 mM ATP pH 7.5 (adjusted with KOH) started the reaction. Activity 
measurements were carried out at 340 nm by oxidation of NADH for every molecule of 3-
phosphatoglycerate phosphorylated.  
Protein concentration. The protein amount present in the samples was estimated according the 
BIO-Rad protocol described by the manufacturer. 
 
 
3.12.3 Glycerol determination 
 
 The protocol was carried out according to Nevoigt & Stahl, 1996. 50 ml YNB pre-
cultures were inoculated and grew overnight at 28°C and 160 rpm until OD600= 1.3-1.5. 
Fermentations were carried out in 100 ml YNB medium inoculated with 10% pre-cultures. 
Anaerobic cultures were grown overnight at 28°C and stirred at 300 rpm until OD600= 1.3-1.5. 
Samples of 10 ml of culture were harvested at 5 K rpm for 10 min in pre-weighed 10 ml 
tubes, 1.5 ml supernatants were transferred to a 1.5 ml fresh cry-tube and frozen by shock 
with liquid N2 and placed at –20 °C. When the determination was taken place 100 µl were 
incubated for 10 min at 80°C to stop possible enzymatic reactions and the samples were 
diluted 1:5 for analyses of glycerol production. Glycerol concentration was determined by 
Glycerol kit (R-Biopharm; Boehringer, Mannheim) and the supplied protocol was followed 
rigorously.  
Pellet obtained were washed two times in distilled water and the tubes were dried for 48 hours 
at 100°C, cooled in a desiccator and reweighed for biomass analyses. 
 
 
3.13 Tetrad analysis 
 
 Strains were grown 2 days in presporulation medium and sporulated after 3-5 days 
after transferring to sporulation medium. The plates were checked for sporulation by 
microscopy. Cells were transferred to a 1.5 ml tube with 600µl distilled water for washing and 
spun at 5K rpm for 5 min, resuspended in 50 µl distilled water, 2.5 µl β-Glucuronidase 
(Sigma) were added and samples were incubated at room temperature for 8 min, 10 µl were 
diluted with 90 µl ice cooled water and the mixture was carefully transferred onto thin YE 
plates using a sterile loop. The four spores were then separated from each other and moved to 
isolated positions on the YE plate using the micromanipulator. The spores germinated and 
formed colonies 3-4 days after dissection. The phenotypes were scored by replica platting 
onto appropriated media. 
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4 Results 
 
4.1 Selection of the hammerhead target sites 
 
As a general rule, the requirement in the target to be cleaved by a hammerhead 
ribozyme is the presence of the NUH triplet where N is any nucleotide and H is any 
nucleotide except G. However, in terms of the cleavage rate the natural GUC triplet is the best 
target for being selected (Amarzguioui & Prydz, 1998). The sequence of the PGK1 mRNA 
contains 24 GUC triplets as possible hammerhead target sites. In order to establish which 
should lead to an efficient catalytic activity, it was analyzed the accessibility of the potential 
target sites for trans-acting ribozymes. The secondary structure fold of the target mRNA was 
predicted at different temperatures (25, 30 and 37°C) applying the “RNA draw” computer 
program (Matzura & Wennborg, 1996). Only two of the 24 GUC triplets could be shown to 
be placed in a single stranded region of the RNA for at least two of the tested temperatures: 
target site one, which is located next to the translation start codon and target site nine, nt 
position at 318 of the ORF. Both of the sites were chosen to design hammerhead ribozymes 
(HH Rz 1 and HH Rz 9) (Fig.7). As a negative control a third ribozyme was designed (HH Rz 
5, ORF position 78 nt), which is located in a region of the PGK1 messenger clearly predicted 
as double-stranded RNA. 
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Figure 7: Secondary structure of three different regions of the PGK1 mRNA selected by 
“RNA draw”. The arrows mark the GUC triplets selected to design trans-acting hammerheads 
for PGK1 mRNA cleavage. 
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4.2 Designing and cloning of hammerhead ribozymes 
 
 For optimal in vivo ribozyme activity, it is well known that the two sequence stretches 
flanking the conserved region of the trans-acting ribozyme, stem I and stem III (see fig. 2) 
should be composed of 15 nucleotides in asymmetrical arrangement (9 and 6 or 8 and 7 nt). 
Thus, DNA oligomer duplexes for the chosen target sites were synthesized, each containing 
the 22 nt of the conserved region and the two flanks of 8 and 7 nt complementary to the 
different target sites (Fig. 8). The 5’ ends were designed as EcoRI overhangs for the cloning 
of the ribozyme sequences into the single EcoRI site of the pIIIEx423 RPR plasmid series 
downstream from the polymerase III promoter (Good & Engelke, 1994). 
 
Rz1 8/7 w GUC: 
5’-AAT TAG ATA AAC TGA TGA GTC CGT GAG GAC GAA ACA TTG TTG-3’ 
Rz1 8/7 c GUC: 
5’-AAT TCA ACA ATG TTT CGT CCT CAC GGA CTC ATC AGT TTA TCT-3’ 
 
 
Rz5 w GUC: 
5’-AAT TTC CAA TGG CTG ATG AGT CCG TGA GGA CGA AAC GTT GAA G-3’ 
Rz 5 c GUC: 
5’-AAT TCT TCA ACG TTT CGT CCT CAC GGA CTC ATC AGC CAT TGG A-3’ 
 
 
Rz9 w GUC: 
5’-AAT TAA GCC TTC TGA GTC CGT GAG GAC GAC GAA ACA GCG GCG-3’ 
Rz 9 c GUC: 
5’-AAT TCG CCG CTG TTT CGT CCT CAC GGA CTC ATC AGA AGG CTT-3’ 
 
 
Figure 8: DNA sequence of the Watson and Crick strand (w and c, respectively) of the three 
cloned trans-acting ribozyme genes. The constructs contain the conserved sequence of the 
hammerhead ribozyme (bold type), the complementary flanks of the targets and the EcoRI 
overhangs for cloning (underlined). 
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4.3 Cloning of the ribozyme DNAs into vectors of the pIIIEx423 series 
 
 In order to get a high ribozyme expression in yeast cells, we used the shuttle plasmid 
pIIIEx423 RPR (see appendix). These vectors, generously provided by D.H. Engelke 
(University of Michigan, Ann Arbor), were derived from the pRS vector series developed by 
Sikorski and Hieter (1989) to promote the accumulation of small RNAs in yeast. The high 
expression is based on the presence of a promoter which is transcribed under the control of 
the polymerase III system. The pIIIEx423 RPR plasmids contain the intragenic promoter from 
the S. cerevisiae RNase P RNA gene (RPR1). This promoter consists of an A box and B box 
within the transcribed leader which is normally removed from the “mature” domain of the 
RNase P RNA. The fusion of this leader to RNAs that are not recognized in RNase P 
maturation process leads to stable accumulation of these molecules (Fig. 9) (Good & Engelke, 
1994). 
 
Figure 9: Schematic representation of the insertion site used for cloning of hammerhead 
ribozymes in the RPR1 leader RNA designed by Good and Engelke (1994). Thus, the 
hammerhead ribozyme encoding sequences were inserted into single EcoRI site of pIIIEx423 
RPR. 
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The correct integration of the ribozyme genes in plasmid pIIIEx423 RPR Rz1, RZ5, 
and Rz9 was confirmed by restriction analysis with BamHI/ EcoRI and separation on a 2.5% 
agarose gel (see fig. 10, lanes 2, 3, and 4). The BamHI/ EcoRI restriction fragment of about 
400 bp corresponds to the sequence between the BamHI restriction site used to clone the 
RPR1 leader into the plasmid pRS423 and the EcoRI insertion site used to clone the ribozyme 
DNAs. The ribozyme DNAs were designed to maintain one EcoRI site at the 3’-end, hence 
producing about a 40 nt longer sequence after cloning. 
 
 
 
 
7.3 Kb 
400 bp
440 bp
 
 
 
Figure 10: Checking the correct insertion of the ribozyme DNAs by restriction-analysis with 
BamHI/EcoRI and separation on a 2.5% agarose gel. Digestion of plasmids pIIIEx423 RPR 
without ribozyme DNA (lane 1), Rz1, Rz5, and Rz9 (lanes 2, 3, and 4, respectively). The right 
arrow shows the bands corresponding to the BamHI/EcoRI fragments carrying the correct 
insertion of the ribozyme expression cassette of about 440 bp. 
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4.4 pgk1-knock-out strain 
 
For disruption of the chromosomal copy of the PGK1 gene, a PCR-based knock-out 
strategy was chosen. The deletion cassette with a kanamycinMX module as a dominant 
resistant marker was amplified from plasmid pUG6 (Gueldener et al., 1996) via PCR using 
two long primers (60 nt) whose 40 nt long sequence stretches at their 5’ ends are homologue 
to specific upstream and downstream sequences of the PGK1 ORF (see chapter 3.1.5). 
 
Due to the difficulty in manipulating the pgk1 knock-out phenotype (inhibited growth on 
glucose), the development of a ∆pgk1 strain made it necessary to use a diploid strain as the 
starting material in order to ensure the viability of this strain. For this reason, the strain CEY 
(see materials and methods) was transformed with the disruption cassette and the 
transformants were selected on glucose media plates containing 100µg/ml Kanamycin 
resistance marker, geneticin 418 (G418). The detection of the correct integration was 
achieved by diagnostic PCR. The kanamycin-resistant diploid transformants contain both the 
sequence corresponding to the inserted disruption cassette in the PGK1 ORF (3917 bp) and 
the sequence encoding for the wild-type PGK1 gene (3244 bp) (Fig. 11, lane 8). 
Subsequently, the transformants were submitted to tetrad analysis and the spore-isolates from 
tetrads, were analyzed with respect to their expected phenotype for the ∆pgk1 strain isolate by 
growth on different carbon sources (Fig. 12). Figure 12 shows that two spore-isolates from 
each tetrad have the phenotype described for ∆pgk1, which is in accordance with a meiotic 
segregation. Therefore, these isolates do not grow on glucose plates but are able to grow on 
glycerol/ethanol plates (YEGE) in the presence of G418. This is the exact knock-out 
phenotype expected and the analysis of the disruption events by PCR of the ORF on these 
haploid isolates revealed a correct integration of the disruption cassette into the PGK1 gene 
(Fig. 13). 
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Primers used for PCR analyses 
PGK1 
  PGK1 ORF   
 
pgk1-5  pgk1-3   G1 
⇒  ⇒   ⇒ 
 
Disrupted gene 
  Kan   
⇐   ⇐ 
G2   pgk1-4 
 
 
 
 
Figure 11: PCR analysis of the correct integration of the kan cassette in kanamycin resistant 
diploid CEY transformants. λ DNA /HindIII marker (lane 1); amplified DNA of a Kan 
resistant transformant using pgk1-4 and G1 (lane 2), pgk1-3 and G2 (lane 4), pgk1-5 and G2 
(lane 6), and pgk1-3 and pgk1-4 (lane 8); amplified DNA of the wild-type strain CEY using 
pgk1-4 and G1 (lane 3), pgk1-3 and G2 (lane 5), pgk1-5 and G2 (lane 7), and pgk1-3 and 
pgk1-4 (lane 9) as a control. 
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YEGE YE
YEGE
(50 µg/ml G418) 
YEGE
(100 µg/ml G418) 
 
 
 
Figure 12: Growth characteristics of different spore-isolates from tetrads of the diploid strain 
CEY PGK1/pgk1::KanMX. The haploid pgk1 knock-out strains are known to grow only on 
media with non-fermentable carbon sources like ethanol and/or glycerol (YEGE), but cannot 
grow on glucose medium (YE). The spore isolates carrying the Kan resistance cassette grow 
on YEGE plates with Geneticin 418 (G418), but are unable to grow on glucose containing 
media. 
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Figure 13: PCR analysis of correct integration of the kan cassette in kanamycin resistant 
diploid transformants and haploid spore isolates using pgk1-3 and pgk1-4. λ DNA /HindIII 
(lane 1); diploid wild-type CEY (lane 2); diploid Kan transformant (lane 3); haploid spore a1 
with ∆pgk1 phenotype (lane 4); haploid spore a2 with PGK1 phenotype (lane 5) and haploid 
spore a3 with ∆pgk1 phenotype (lane 6). 
 59 
4.5 Delivery of hammerhead ribozymes 
 
In order to analyze the factors that are involved in the catalytic in vivo activity, the 
hammerhead ribozymes and the PGK1 gene were delivered into the pgk1 knock-out and wild-
type strain using three different approaches (Fig. 14): 
 
 
1. Two-plasmid-system: The PGK1 gene was amplified from total yeast DNA by PCR using 
pgk1-3 and pgk1-4 primers (see above), and cloned into vector pGEM-T. The PGK1 gene 
was re-cloned from pGEM-T as a SacII/SpeI fragment into yeast/E. coli shuttle vector 
pRS416 (Sikorski & Hieter, 1989) to give rise to pRS416-PGK1 and co-localized with the 
pIIIEx423 RPR ribozyme constructs (see appendix). The ∆pgk1 strain was subsequently 
transformed with pRS416-PGK1 and the pIIIEx423 RPR plasmids, with and without 
ribozymes. This strategy is straight to analyze the effects of the nuclear localization of the 
ribozymes and the target molecule in the cleavage activity. 
 
2. One-plasmid-system: The pIIIEx423 RPR Rz and pIIIEx423 RPR were digested with 
BamHI/XhoI and the fragments carrying the expression cassette with and without ribozymes 
(as a negative control) were inserted into the single BamHI/XhoI sites of plasmid pRS416-
PGK1 (see appendix). The correct insertion was checked by restriction assays (see figure 7, 
lanes 1, 3 and 5). The ∆pgk1 strain was transformed with the pRS416-PGK1-RPR1 Rz and 
pRS416-PGK1-RPR1 plasmid, respectively. This approach might produce a highly productive 
ribozyme-target interaction since the delivery of both genes is via a co-expressing trans-acting 
ribozyme/target plasmid. 
 
3. Simple-plasmid-system: The wild-type strain was transformed with the pIIIEx423 RPR 
plasmids with and without ribozymes. This model should shed light on how the chromosomal 
target localization influences ribozyme activity. The activities obtained using this system can 
be compared to those from the one- and two-plasmid-system where the target PGK1 gene is 
localized on a plasmid. 
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High degree of co-localization
High degree of co-localization
Productive ribozyme-target interaction
1. Two-plasmid system
2. One-plasmid system
3. Simple plasmid system
PGK1 wild-type strain
pgk1 knock-out strain
Chromosomal target localization
 
 
 
 
Figure 14: Ribozyme-delivery strategy. This schematic model presents the three systems used 
for ribozyme expression in yeast cells for determining cellular factors involved in cleavage 
activity. 
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4.6 Detection of cleavage activity 
 
The ribozyme cleavages activities were tested by in vitro and in vivo assays. 
 
4.6.1 In vitro assays 
To examine whether the ribozymes had the predicted cleavage activity from their 
secondary structures and to establish the influence of the ribozyme insertion into the RPR1 
leader on the cleavage reaction, the cleavage activities were compared in vitro. RNA was 
synthesized in vitro with T7 RNA polymerase. Different primers were designed to amplify the 
corresponding encoding ribozymes and the target sequences were under the control of the T7 
promoter control. These fragments were used for in vitro transcription where the complete 
PGK1 mRNA was labelled by [α32P] UTP incorporation. The transcription products were 
used to test the cleavage activity by cleavage reaction assays for every ribozyme (Fig. 15). 
Cleavage reactions were performed at 37°C for 60 min and cleavage products were separated 
on a denaturing polyacrylamide gel. As the template for transcription a PGK1 fragment of 
1379 bp was amplified from pRS416 using the primers pgk1-tsp and pgk1-ter. The Rz 
templates were amplified from the pIIIEx423 RPR with and without ribozymes genes by 
using the primers rpr1-tsp and rpr1-ter. RPR1 means RPR1 leader without ribozyme. The 
cleavage control used was substrate incubated without ribozyme in presence of 10 mM Mg2+. 
As expected, the cleavage reaction of Rz1, showed a weak band corresponding to the small 40 
nt 5’ cleavage product of PGK1 RNA and its accumulation increased when a greater 
concentration of RZ1 was added in the cleavage reaction, i.e. single turnover was established. 
On the contrary, there was no evidence for any cleavage activity of Rz5 and Rz9. But the 
resolution of this assay by using long PGK1 transcripts as substrates was not sensitive enough 
to draw clear conclusions. 
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Figure 15: Cleavage of the PGK1 target by hammerhead ribozymes. The PGK1 RNA 
fragment was internally labelled with [α32P] UTP and incubated with each of the individual 
ribozyme cassettes to cleave the selected sites. 
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4.6.1.1 Improving the in vitro assays 
 
Due to the difficulties found when detecting the in vitro cleavage activity, a new 
cleavage reaction was performed under different conditions. A short 5’ fragment from the 
PGK1 sequence was amplified at the start transcription codon, considering also the 3' sites 
selected, thus a 422 nt substrate was obtained to be cleaved by ribozymes. Furthermore, in 
order to improve the resolution, an internal label procedure was developed by the 
incorporation of [α35S] UTP. The [α32P] UTP results in diffuser and bigger bands that hamper 
the detection of sequences with little differences in size (smaller than 40 nt). The labelling of 
probes with [α35S] UTP generates thin bands after detection by autoradiography. However, it 
is not known until now how the cleavage activity is affected due to the incorporation of [α35S] 
labelled UTP at the GUC codon. 
The cleavage reaction was performed under standard conditions. The cleavage 
products were separated on a denaturing polyacrylamide gel. As the template for transcription 
a PGK1 fragment of 422 bp was amplified from pRS416 using the primers pgk1-tsp and 
pgk1-9. The Rz templates were amplified from the pIIIEx423 RPR carrying the ribozyme 
genes by using the primers rpr1-tsp and rpr1-ter. The cleavage control used was substrate 
incubated without ribozyme in presence of Mg2+. The cleavage activity of Rz1 with the 
expected 3’ cleavage product (382 bases long) was observed. Single turnover was confirmed 
by using increased concentrations of ribozymes (Fig. 16 B).  
To analyze the influence of longer flanks, we designed two new ribozymes (Fig.16 A). 
These constructs were cloned, amplified and in vitro transcribed as mentioned above for 
expressing ribozymes. The cleavage activities were enhanced and the expected 3’-cleavage 
product was accumulated (Fig. 16 B). The reaction was increased about 20 % by using 11/10 
flanks and 40% by using of 14/13 flanks. Furthermore, we tested the catalytic activities of 
Rz5 and Rz9. As expected and demonstrated previously, no cleavage activity was detected for 
Rz5. However, Rz9 did not show the cleavage activity predicted. Only very weak bands 
corresponding to the 5'-cleavage products were observed despite the increased Rz 
concentration. Thus, the cleavage activity of hammerhead ribozymes in vitro could be 
partially deduced from their computer-generated secondary structures. Additionally, we 
designed the Rz transcripts that contained the whole secondary structure of the ribozyme 
cassette. With this experiment it was demonstrated that the ribozymes inserted into this 
folding sequence could bind and cleave the target molecule appropriately, at least in vitro. 
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Moreover, the cleavage activity assays revealed that the use of internally labelled 
RNA by radioactive [α35S] UTP does not have an inhibitory effect on catalysis. 
 
A. Oligonucleotides 
 
Rz1 11//10 w GUC: 
5 '-AAT TTG AAG ATA AAC TGA TGA GTC CGT GAG GAC GAA ACA TTG TTT TAG-3' 
Rz1 11/10 c GUC: 
5 '-AAT TCT AAA ACA ATG TTT CGT CCT CAC GGA CTC ATC AGT TTA TCT TCA-3' 
 
Rz1 14//13 w GUC: 
5 '-AAT TTC TTT GAA GAT AAA CTG ATG AGT CCG TGA GGA CGA AAC ATT GTT TTA TAT G-3' 
Rz1 14/13 c GUC: 
5 '-AAT TCA TAT AAA ACA ATG TTT CGT CCT CAC GGA CTC ATC AGT TTA TCT TCA AAG A-3' 
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Figure 16: Cleavage activity detection. A. DNA sequence of both strands (w and c) of the two 
cloned trans-acting ribozyme genes designed with longer flanks. The constructs contain the 
conserved sequence of the hammerhead ribozyme (bold type), the complementary flanks of 
the targets and the EcoRI overhangs for cloning (underlined). B. Cleavage reaction of the in 
vitro PGK1 small transcript internally labelled with [α35S] UTP. The PGK1 transcript was 
incubated with each of the individual ribozyme cassettes to cleave the selected sites. Cleavage 
reactions were started by adding magnesium and performed at 37°C for 60 min. 
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4.6.2 In vivo assays 
 
4.6.2.1 Effects of ribozyme-delivery on growth rates 
 
For an initial physiological characterization and to enable comparison of ribozymes 
directed to different PGK1 RNA sites, the wild-type and ∆pgk1 strains were transformed 
following the described strategy. The growth rates were determined in shake-flask cultures on 
minimal media with glucose at 30°C in aerobic conditions. This determination should indicate 
the direct influence of the transformation procedure and the plasmid type used on growth. 
In minimal medium, all the transformants have a slower growth than the wild-type 
strain. The growth rates of strains transformed with Rz1 in the simple- and two-plasmid 
system differ from the wild-type and the control strain transformed with plasmids without 
ribozyme, showing a slower growth than any of the other strains (compare fig. 17 A and 17 
B). This result might be consistent with the fact that the phosphoglycerate kinase is involved 
in glucose metabolism and a low expression during growth on glucose containing media leads 
to a reduction of the specific growth rate. Nevertheless, the one-plasmid system transformant 
for Rz1 did not show any effect as neither did the Rz5 and Rz9 transformants. This is 
expected from the results obtained for both ribozymes Rz5 and Rz9 in the in vitro assays. 
Considering that the ribozyme expression cassette is cloned into a low-copy-number plasmid, 
the presumably low level of expression reached might lead to Rz1 activities being to low to be 
detected. 
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C. 
 One-plasmid system growth curves 
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Figure 17: Growth rates of S. cerevisiae strains on minimal media containing glucose as the 
sole carbon source (YNB). 
A. Growth curves for Simple system. Wt correspond to wt strain (CEY 1118-6B). Rpr1, rz1, 
rz5, and rz9 correspond to the strains derived after transformation of the wild-type strain with 
pIIIEx423 RPR without Rz, carrying Rz1 8/7, Rz5, and Rz 9, respectively. 
B. Growth curves for Two-plasmid system transformants. Rpr1, rz1 8/7, rz5, and rz9 
correspond to the ∆pgk1 strain transformed with pRS 416-PGK1 and pIIIEx423 RPR without 
Rz, carrying Rz1 8/7, Rz5, and RZ9, respectively. 
C. Growth curves One-plasmid system. Therefore, rpr1, rz1, rz5, and rz9, correspond to 
∆pgk1 strain transformed with pRS 416 PGK1 RPR1 without Rz, carrying Rz1 8/7, Rz5, and 
Rz9. 
Shake-flask cultures were grown at 30°C in aerobic conditions. 
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4.6.2.2 Analysis of PGK1 gene expression and RNA cleavage activity of the 
transformants  
 
 To compare the level of PGK1 transcripts in the transformants with the wild-type 
haploid strain, we analyzed PGK1 RNA accumulation by northern analysis (Fig. 18). The 
transformants were grown on YEPD media and total RNA was isolated. When looking for 
cleavage activity, two probes were tested; one probe was directed to the PGK1 ORF to look 
for the 3’ cleavage products present (Fig. 18 top panel) and a second probe was developed for 
hybridization to the 5’ untranslated region (5’UTR) (Fig. 18 middle panel). The analysis of 
transcription level and presence of 5’cleavage products was performed with a 611 bp 
fragment from the Pgk1 coding region (orf probe) generated by PCR using primers pgk1-6 
and pgk1-7. For determining the presence of 5’ cleavage products, oligonucleotide pgk1-0 
was labelled by polynucleotide kinase. The samples were balanced with S. cerevisiae actine. 
The actine probe was generated by PCR using primers Actine-1a and Actine-1e. The strains 
transformed with the plasmid carrying the Rz1 with 8/7 flanks from each system were used in 
this experiment.  
The analyses showed similar PGK1 mRNA levels for all the transformants. Thus, it 
was not possible to verify the presence of any cleavage products for any of the tested 
transformants from this experiment. 
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Figure 18: PGK1 expression analyses by Northern blotting. The transformants and wt strains 
were grown on YEDP at 30 °C and total RNA was isolated, blotted and hybridized with the 
PGK1 probes. The S. cerevisiae actine was used as internal control for balanced RNA 
loading. 
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4.6.2.3  Pgk1 activity assays 
 
Effects of trans-cleavage ribozyme activity on the phosphoglycerate kinase were 
investigated by measuring enzyme activity in cell-free extracts of wild-type S. cerevisiae, 
CEY 1118-6B, and in transformants from simple, one-plasmid, and two-plasmid systems. The 
assay principle is based on the phosphoglycerate kinase reaction which is coupled to the 
previous enzyme in the glycolytic pathway, glyceraldehydes-3-phosphate dehydrogenase, 
resulting in the oxidation of 1 molecule of NADH for every molecule of 3-phosphoglycerate 
phosphorylated (see fig. 19 A). Thus, the decrease in the PGK1expression can be measured by 
a decrease in the absorbance of NADH at 340 nm. The cells were grown in minimal media 
containing glucose as the carbon source at 30°C. To ensure reproducible results, all cultures 
were grew to OD600 =0.5- 0.7. The activities were related to the total protein content. 
Phosphoglycerate kinase activities in simple and one-plasmid-system strains 
transformed with plasmids carrying ribozymes were not significantly different from the 
activities in strains transformed with the control plasmid without ribozymes. The activities in 
Rz5 and Rz9 transformants strains of the two-plasmid system did not show any reduction. 
However, the Rz1 transformant strain for this system showed a lower activity in comparison 
to the control strain. The reduction of the Pgk1 activity might be a direct effect of the Rz1 
catalytic activity on the PGK1 expression (Fig. 19 D). 
 
 
A. Pgk1 activity assay 
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D. 
Two-plasmid system Pgk1 Activities
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Figure 19: Analyses of the Pgk1 activity. A. Schematic representation of the glycolytic 
pathway part used to determine the Pgk1 activity. B, C, D. Specific phosphoglycerate kinase 
activities of transformant strains. For enzyme activity assays, free extracts were obtained from 
log phase cells grown on minimal medium (YNB). 
 73 
4.6.2.4 Effects of ribozymes on glycerol production 
 
From the activity assays, it was not possible to clearly determine to what extent the 
PGK1 expression was influenced by trans-acting ribozyme when measuring indirectly the 
enzyme activity. Therefore, it was decided to analyze the effect of the PGK1 expression on 
glycerol synthesis, which is formed as a by-product when S. cerevisiae ferments sugar to 
ethanol. If the PGK1 expression is reduced, this should lead to an increase of the glycerol-3-
phosphate production. To carry out this analysis, we determined the concentration of glycerol 
secreted into the media in relation to biomass for each strain after growth under anaerobic 
conditions in minimal medium. The measuring of glycerol in anaerobic conditions avoids the 
consumption of this metabolite as carbon source in the stationary phase. 
The results obtained from the simple system showed, as it was expected that Rz5 (as 
inactive ribozyme control) and Rz9 did not exhibit any influence on the glycerol production. 
An increment on the glycerol yield in the Rz1 transformed strain was detected. However this 
increment is not relevant for strains transformed with Rz1 designed with longer flanks. Thus 
the level of glycerol production was similar to the control strain transformed without 
ribozymes (Fig. 20 A). These results are consistent with approaches reported by Lieber and 
Strauss. They observed that despite good in vitro activity, ribozymes designed with longer 
flanks did not show the expected in vivo activity (Lieber & Strauss, 1995). For this reason, 
only the RZ1 with 8/7 flanks transformants were analyzed in the one-plasmid and two-
plasmid systems. Comparing the glycerol production for the different systems transformed 
with Rz1, an increment was observed with the two-plasmid system but no effect could be 
detected for the one-plasmid system (Fig. 20 B). The controls used in these systems produced 
less amounts of glycerol than the wild-type srain. This could indicate the influence on the 
glycolytic pathway caused by transformation with this kind of plasmid and/or the promoter 
types used. 
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Figure 20: Glycerol amounts in transformed strains after anaerobic growth in minimal 
medium. Glycerol yields were expressed in relation to biomass (as dry weight). The strains 
were grown under anaerobic conditions on minimal medium with glucose for 24h (starting up 
OD600= 0.1-0.15), to the early stationary phase, and collected for glycerol and dry weight 
analysis. A. Comparison of glycerol production in Simple system transformants and the 
influence of longer flanks. B. Glycerol production from Rz1 8/7 transformants in all three 
systems. 
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4.7 Ribozyme expression 
 
 Based on the data presented previously (see chapter 4.6.2), it is important to know 
whether or not the ribozyme cassette is expressed at the expected level for every system. The 
simple and two-plasmid system must have a high ribozyme expression, because the pIIIEx423 
RPR vector is a derivative of a high-copy-number plasmid including the RPR1 promoter 
which has a high transcription rate (Fig. 21 A). Besides, the one-plasmid system should have 
less transcript accumulation since pRS416 is a low copy plasmid (one or two copies per cell) 
(see appendix). Because of this, the ribozyme expression was analyzed by northern blot. The 
probe was generated by PCR using the rpr1 ter and rpr1 tsp primers for amplifying the 
sequence corresponding to the whole ribozyme cassette (See material and methods). The 
analyses confirmed a high transcript accumulation in the high-copy-number plasmid used for 
ribozyme expression, i.e. the simple and the two-plasmid system. As can be seen in fig. 21 B, 
cassettes carrying the ribozymes migrate slower on 1.2% agarose-formaldehyde gels than 
cassettes without ribozymes (see fig 21 B line rpr1 in relation to rz1, rz5, and rz9). This 
confirms again, effective ribozyme insertions into the plasmids. The one-plasmid system 
however showed a very weak signal for ribozyme expression. This might be consistent with 
the absence of cleavage activity detected (Chapter 4.6.2.4) although the same nuclear 
localization of ribozymes and PGK1 target gene is present in this system. Unexpectedly, a 
high ribozyme expression is observed for Rz5 and Rz9 inserted into high copy numbers 
plasmids. The data also support the previously obtained results, i.e. these Rzs are not 
catalytically active in vitro as well as in vivo in spite of the high accumulation shown. 
Moreover, it was possible to detect the accumulation of the endogenous wild-type RPR1 
transcript in every transformant. 
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Figure 21: Ribozyme expression analysis. A. vector map of pIIIEx423 RPR used for ribozyme 
expression. B. Ribozyme expression of the different systems using Northern blot analysis. 
Total RNAs were isolated, blotted and hybridized with the RPR1 probes. The S. cerevisiae 
25/26 S and 18 S RNAs were used as internal control for equivalent RNA loading. The wild-
type strain, a two-plasmid system control strain (∆pgk1 transformed with pRS416 PGK1 used 
as expression control) and the transformants were grown at 30 °C in minimal medium. 
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4.8 Improving the co-localization of ribozyme and target RNA 
 
In order to have a higher catalytic efficiency on the Rz1 transformed strains, we decided 
to take advantage of the properties of some messenger RNAs to localize within specific sub-
cellular compartments. In eukaryotic cells, sub-cellular localization signals for several 
mRNAs are positioned in the 3’UTRs. Recently, it was shown for S. cerevisiae that the ASH1 
mRNA localizes into a discrete particle that is maintained at the bud tip and cis-acting 
sequences within the 3’untranslated region for this mRNA are recognized by specific target 
molecules that are required for its nuclear export and localization (Beach et al., 1999). Later 
on it was reported that the behavior of mRNAs in nuclear transport mutants is different. 
Under stress conditions some transcripts appear to fill the nucleus and others accumulate in 
the nucleolus when the export is blocked. Thus, these results show the existence of a link 
between mRNA processing and nuclear export (Brodsky & Silver, 2000). In human cells and 
Drosophila oocytes the use of catalytic RNAs to reduce the expression was successful when 
they were co-localized to the same intracellular compartment by using the discrete 3`UTR of 
the target RNA. These signals were fused to the targets and ribozymes, and it was possible to 
achieve a two- to three-fold enhancement of ribozyme function compared with non-co-
localized transcript (Lee et al., 2001 and 1999). Based on these approaches a new ribozyme 
transcript was created. The terminator region of the RPR1 was replaced by a sequence 
amplified from the pRS416 PGK1 plasmid containing the 3’UTR sequence of PGK1 
described by Brodsky and Sylver (2000). The Rz1 8/7 was inserted into the pIIIEx423 RPR 
vector as described above. Primers 3’UTR stp (1) and 3’UTR ter (2) were used for amplifying 
the corresponding PGK1 3’UTR from the pRS416 PGK1 plasmid. This fragment was 
digested with EcoRI/XhoI and ligated to the pIIIEx423 RPR Rz1 8/7 plasmid. The pIIIEx423 
RPR Rz1 8/7+ PGK1 3’UTR was used for transforming the wild-type strain CEY 1118-6B 
(see fig. 22). 
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Figure 22: Schematic representation of the construction of the cassettes used for testing 
ribozyme target co-localization with the PGK1 3’UTR. 
 
The Simple system was used to establish the influence on the glycerol production. 
This system was chosen due to its better growth-rate of the Rz1 transformant compared to the 
two-plasmid system. Therefore, the wild-type strain was again transformed with this new 
plasmid. The effects of introducing the PGK1 3’UTR sequence were compared with the Rz1 
8/7 transformant and the control strain (without ribozyme) by glycerol formation (Fig. 23). 
The introduction of the PGK1 3’UTR yield a 20% increased glycerol production in relation to 
the control strain without Rz. This enhancement on the glycerol production was observed in 
all of the six transformants analyzed. As an example, the value shown here belongs to the 
transformant strain number 2 (pIIIEx423 RPR Rz1 + PGK1 3’UTR (2)). 
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Figure 23: Glycerol production following introduction of the PGK1 3’UTR into the ribozyme 
expression cassettes. 
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4.9 Determining in vivo catalytic activity using primer extension 
 
 The experiments analyzed until now show an influence on the glycerol production in 
the simple and the two-plasmid system by insertion of Rz1 8/7 into the RPR1 cassette. This 
accumulation could be due to the cleavage of the PGK1 mRNA. However, so far no cleavage 
activity could be detected. The northern blot experiments did not show any presence of the 
expected cleavage products. Considering that Rz1 is cleaving only 40 nt downstream of the 
transcription start point, the resulting size of the 5'-cleavage product also makes the detection 
difficult. Thus, to determine the presence of a cleavage product, a primer extension was 
carried out. To test the primer extension conditions (reverse transcription, synthesis of cDNA) 
with the 3’ cleavage product as template, samples from successful in vitro cleavage reaction 
were analyzed (Fig. 24 A). The cleavage product corresponding to the 3’ end could be 
detected by primer extension. Therefore, in order to confirm cleavage activity in vivo, poly 
(A)+ mRNA was isolated and subjected to reverse transcription (Fig. 24 B). The Rpr1, rz1 8/7, 
rz1 14/13, and rz1+ 3’UTR lines, correspond to the reverse transcription reactions from wild-
type strain transformed with pIIIEx423 RPR without Rz, with Rz1 8/7, Rz1 14/13, and Rz1 
8/7 + PGK1 3’UTR, respectively. All the samples were incubated for 4 hours with M-MuL V 
reverse transcriptase and primer pgk1-11 at 37°C, DNA fragments were internally labelled 
with [α35S] ATP. 
Despite all the efforts made for having an amplification of the 3’cleavage product, 
modification of the test conditions, incubation time, binding time, and specific primers, it was 
not possible to detect the expected cleaved product. 
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Figure 24: Primer extension analysis of the in vitro and in vivo ribozyme cleavage activity. A. 
Detection by primer extension of ribozyme mediated cleavage by RZ1 8/7 on the in vitro 
PGK1 transcript fragment; pgk1-8 was used as nested primer. B. poly (A)+ mRNA isolated 
from Simple system transformants were analyzed by primer extension. 
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4.10 Regulated ribozyme delivery 
 
 While investigating whether the delivering of ribozymes can be regulated, the CUP1 
promoter was tested to transcribe hammerhead ribozymes. This analysis was carried out 
within the framework of a diploma thesis. The pYEX-BX, which has the CUP1 promoter, was 
used to clone ribozymes-encoding sequence into the EcoRI site. The RPR1 carrying the Rz 
cassettes was also cloned into the BamHI/PstI of pYEX-BX restriction sites for comparing the 
catalysis by delivering ribozymes inserted into the stable secondary structure of RPR1 
transcripts (see fig. 24). The in vivo cleavage activity was determined by glycerol formation 
by growing the transformant strains on different copper concentrations. These experiments 
did not show any improvement on the glycerol production, and the transformants showed a 
lower level of glycerol formation than the wild-type indicating that the high copper 
concentration was to same extent toxic for S. cerevisiae (for more details please refer to the 
diploma thesis of Nicole Abdallah “Expression of trans-acting ribozymes in Saccharomyces 
cerevisiae under the control of the CUP1 promoter, TU-Berlin 2003”). 
 
 
 
 
Figure 25: Schematic representation for the construction of regulated expression vectors. A. 
Design of pYEX-BX-RZ plasmid. B. Design of pYEX-BX RPR1 ribozymes plasmids. 
 83 
5 Discussion 
 
5.1 Selection of sites for ribozyme design 
 
The ribozyme cleavage activity was tested using in vitro and in vivo standard methods. 
The in vitro assays revealed that Rz1 and Rz5 had the expected cleavage activities (Chapter 
4.6.6.1). Hence, the level of accuracy of the computer algorithms used for secondary structure 
predictions is questionable and additionally they do not predict higher order structure. 
The analysis of in vitro experiments to predict in vivo cleavage activity is limited. Many 
factors inside the cell affect the cleavage reaction. Low free Mg+2 concentrations, stability and 
compartmentalization of ribozymes must be considered, as well as substrate RNA 
conformation and RNA binding proteins. The mRNAs are associated with heterogeneous 
nuclear ribonucleoproteins in the nucleous. When transport to cytoplasm takes place they are 
replaced by cytoplasmic ribonucleoproteins. All of these proteins can hamper or have an 
influence on the RNA folding and thus avoid the access of ribozymes to the targets. 
The in vitro activity does not guarantee efficient in vivo activity, although the relative 
efficacy in vivo can be expected to correlate with the relative efficacy in vitro (Birikh et al, 
1997). 
It was confirmed that ribozymes designed at the 5'-end had much more efficacy. Rz9 
located at 318 nt of the ORF the in vitro activity was almost undetectable and did not have in 
vivo activity. On the contrary, Rz1 was designed for cleaving at the start codon site which was 
previously successfully reported for reducing the ADE1 expression in yeast. This sequence is 
located in a region which is accessible and therefore effective for the designing of trans-
acting hammerhead ribozymes (Ferbeyre, et al, 1995). The 5'-end was also a good target for 
hammerhead ribozymes to suppress telomerase activity in mammalian cells. A ribozyme 
targeting 13 nucleotides downstream from the 5'-end of hTERT, a catalytic subunit of human 
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telomerase, exhibited the strongest telomerase-inhibitory activity. The future trial is the 
application of this hammerhead ribozyme as a potential anti-cancer agent which indicates the 
confidence in this design (Yokoyama et al., 2000).  
The sequence analyses revealed that all the ribozyme genes were inserted at the right 
position into the ribozyme expression cassette in pIIIEx423 RPR plasmids. Therefore, 
ribozyme sequences obtained for Rz1 8/7, Rz1 11/10, Rz1 14/13, and Rz9 had the expected 
sequences corresponding to the chemically synthesized oligonucleotides created for this 
purpose (see appendix). Moreover, the RPR1 terminator region was switched correctly by the 
PGK1 untranslated region in pIIIEx423 RPR Rz1 8/7. 
Unfortunately, the sequence analysis of Rz5 revealed a punctual deletion. Hereby a base 
deletion was observed corresponding to G at the catalytic core sequence (see Fig. A 8): 5’ 
GTG AG(G) ACG AAA 3’ (Fig. 27). However, whether this change had an influence on the 
absence of catalytic activity reported here is unknown. This base was a G placed at stem II 
and does not belong to the two stretches of highly conserved sequences reported previously 
by Haselhoff and Gerlach (1988) 5’-CUGANGA and 5’GAAG, respectively. The length of 
the stem II has a larger influence on ribozyme activity than the nucleotide loop that terminates 
the stem II. Stems shorter than two base pairs are less active than those with two or more 
bases pairs. However, some ribozymes designed with shorter stem II which could cleave with 
almost full activity have been reported. These ribozymes could also cleave long RNA 
transcripts faster than wild-type ribozymes (Birikh et al, 1997, McCall et al., 2000). 
Nevertheless, the cleavage reaction carried out with Rz5 revealed that this ribozyme was 
inactive under any conditions.  
 
With respect to the asymmetrical design chosen, the catalytic activities obtained in this 
work confirm the fact that for single turnover, the length of the arms is important for an 
efficient catalytic in vitro activity. In this experiment, high concentrations of ribozymes were 
 85 
used, so that all the substrate molecules should be in a complex with the ribozymes. In vitro, 
the ribozyme designed with 13 and 14 bp flanks respectively, was the most active one. 
However, in vivo this ribozyme did not show the expected cleavage activity that is consistent 
with previous results obtained by Lieber and Strauss. They conclude that in vivo the most 
active ribozyme is a molecule with a 7 and an 8 bp helix (Lieber & Strauss, 1995). In vivo, the 
dissociation rate must be considered when multiple turnovers are required, in order to cleave 
most of the target molecules. The rate of dissociation of cleavage products is expected to 
consistently decrease with increasing length arms (McCall et al, 2000; Ferbeyre et al., 1996). 
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5.2 Use of pIIIEx423 RPR for ribozyme delivery and its influence on the metabolism 
 
The plasmids constructed to transform the yeast for ribozyme delivery have a direct 
influence on the metabolism. In the in vivo assays, measuring the effects of the ribozyme on 
the growth rates and glycerol production (chapters 4.6.2.1 and 4.6.2.4), a comparison of the 
transformants with the wild-type strain revealed that the transformants have a slower growth 
and slower glycerol production than the untransformed strain. This observation has been 
reported previously. In recombinant gene expression, the possibilities to introduce a non-
specific "metabolic burden" negatively affecting the growth have been described in numerous 
organisms. In yeast, reductions of the specific growth rate, biomass, respiratory capacity, and 
stability have been observed along with a decrease in the glycolytic flux and an increase in the 
maintenance energy requirement. This effect increases with the production levels, either due 
to the plasmid copy number amplification or an increase in the strength of the recombinant 
promoter. The effect of the cloned expression may be associated with either energetic cost of 
extra protein synthesis or the competitive effect. The dilution of native proteins was also 
suggested as a major mechanism causing a decrease in the flux through the glycolysis and in 
the maximum specific growth rate. The foreign protein synthesis during plasmid replication, 
toxicity of recombinants proteins and the negative consequences of small amounts of read 
through transcripts may also play an important role. In multi-copy plasmid transformed 
strains, factors such as the quantities or activities of the transcription and translation initiation 
factors, enzymes essential for expression, the amount of ribosomes, ribosomal activity, 
availability of biosynthetic precursors and metabolic energy needed for gene expression plus 
protein synthesis, may be the bottleneck for efficient gene expression (Goergens et al., 2001; 
Van der Aar et al., 1992). 
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It has been reported that the transformation with a gene which is already contained in the 
host, is not a selective advantage and may place a "metabolic burden" on the transformed 
strain inducing a low growth rate and poor mass yields (Ayub et al., 1992). pIIIEx423 RPR 
used for ribozyme expression has a truncated copy of the RPR1 gene, its wild-type gene is 
also found on the host used for transformation. Thus, the RPR1 gene used as the cassette for 
ribozyme delivery could indeed cause slow growth of the transformants. 
Moreover, in budding yeast actively transcribed pol III genes can negatively regulate 
adjacent RNA polymerase II (pol II)-transcribed promoters. This silencing was observed by 
sub-nuclear localization of the tRNAs. The association of early tRNAs to the nucleolus had a 
negative influence on the HIS4 expression when this promoter was cloned adjacent to the 
HIS4 gene in a (ars6/cen4) copy plasmid. The proximity to pol III transcription units might be 
used as a regulatory strategy in eukaryotes, the pol II transcription units near tRNA genes is 
non-random and the proximity affects the pol II units (Kendall et al., 2000). 
Taken together these observations it is likely that the use of high-copy-number plasmids 
designed for expressing a high level of ribozymes in order to suppress the expression of a 
glycolytic gene negatively affects the glucose metabolism. 
Despite the influence of pIIIEx423 RPR on the metabolism, the catalytic function of the 
ribozymes seems not to be affected by the vector. The cleavage activity could even be 
determined by an increment of glycerol production in Rz1 transformants. Moreover, the RPR1 
cassette was successful in expressing high levels of ribozymes. The northern-blot analyses 
demonstrated the high ribozyme transcript accumulation reached in the transformants (chapter 
4.7). Furthermore, the secondary structure of the RPR1 leader did not interfere with the in 
vivo and in vitro cleavage-activity of the ribozymes. The in vitro cleavage-activity analyses 
revealed that the ribozymes expressed into the RPR1 secondary structure were able to bind 
and cleave the PGK1 target efficiently (chapter 4.6.11). In vivo analyses also demonstrated 
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that strains transformed with Rz1 expressing-plasmids, accumulated greater glycerol than the 
controls (chapter 4.6.2.4) which confirms the use of the RPR1 leader as successful cassette for 
ribozyme expression. 
 
5.3 High interaction of target and ribozymes (one-plasmid system) 
 
Despite the close location of the ribozymes and the target PGK1 genes when using the 
pRS416 PGK1 RPR1, the ribozyme activity was not effective in the one-plasmid system. The 
activity assays and glycerol-production determination did not show any effects caused by 
ribozyme activity. When compared to the simple-plasmid system and the two-plasmid system 
this could be a result of the low level of ribozyme expression obtained. Northern-blot analyses 
confirmed a low accumulation of ribozymes transcripts in these strains (See chapter 4.7). 
Thus, the amount of ribozyme molecules might be not sufficient to cleave the PGK1 
transcripts in order to get any influence on the protein and glycerol level. 
However, another factor that could be involved is the different polymerase machineries 
used for each gene expression: pol II for PGK1 and pol III for the ribozyme. It has been 
documented that the RNA polymerase II transcription process is located in specialized places. 
The sub-nuclear location of the transcription machinery in eukaryotic cells was investigated 
by computer assisted-microscopy. These results show that RNA polymerase II transcription 
takes place at discrete sites scattered throughout the nucleoplasm and that these sites are also 
the locations of pre-mRNA processing. The active polymerases appear to be grouped into 
clusters at each transcription site, and certain sub-nuclear domains appear specialized for the 
expression or silencing of particular genes with a dynamic arrangement of transcription in the 
nucleus (Szentirmay & Sawadogo, 2000). Therefore, when an event takes place such as the 
transcription itself, it is possible that the organization of the whole nucleus makes the 
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expected ribozyme-target interaction unsuccessful in the one-plasmid system. The spatial 
organization important for gene-expression involves a different distribution of the transcripts.  
Moreover, it has been described that tRNA processing is located in the nucleolus 
alongside ribosomal biogenesis. The RNase P which cleaves the 5' termini of pre-tRNAs, and 
pre-tRNAs were accumulated at this place, suggesting that the biogenesis of at least some 
tRNAs begins with the transcription at the nucleolus or nascent transcripts are transported to 
the nucleolus for being processed (Bertrand et al., 1998). Therefore, it is possible that 
ribozymes which are inserted into an RNase P RNA leader and the PGK1 transcripts are 
spatially separated both during and after transcription. This spatial distribution did not have 
any influence on the other tested systems simple and two-plasmid system, since the high 
ribozyme expression obtained might be feasible to influence the glycerol yield. 
 
5.4 High degree of compartmentalization (two-plasmid system) 
 
The effects observed for the two-plasmid system in comparison with the simple system, 
did not show major differences despite the slower rate of growth reached in the two-plasmid 
system than in simple system Rz1 transformants (Chapter 4.6.2). Such an approach could 
indicate a greater effect on the glycolysis due to a greater reduction of the PGK1 expression 
which would directly affect the growth in glucose. 
The two-plasmid system has a PGK1 copy cloned into pRS416 which is a low-copy-
number plasmid designed to have an episomal replication. In the simple system, the PGK1 
gene is located at the wild-type locus. Therefore, the nuclear co-localization of the ribozyme 
and the target gene seems to be less important in comparison to the messenger co-localization 
and high level of ribozyme expression. 
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5.5 Enhancement on the glycerol production by ribozyme co-localization signals 
 
A higher ribozyme/target interaction could be possible when the 3' UTR of the PGK1 was 
used as terminator in the RPR1 cassettes. This could lead to a cytoplasmic accumulation of 
ribozymes. The level of glycerol reached in Rz1 8/7 + PGK1 3' UTR transformants was 
greater than in the strain transformed with Rz1 8/7 + RPR1 terminator sequence (See chapter 
4.8). The co-localization of ribozymes and their target RNAs is the major determinant of high 
level activity of ribozymes in vivo. The transport, anchoring and translation regulation of 
localized transcript are governed by proteins that form large ribonucleic complexes with the 
mRNAs. Messenger RNA molecules are exported from nuclei as ribonucleoprotein particles. 
Many components which play a crucial role in poly (A)+ RNA export have been characterized 
as nucleporines, shuttling transport factors, helicases and exonucleases (Hurt et al., 2000). The 
process of specific localization is often mediated by cis-acting elements within the 3' 
untranslated region of the transcript. For instance, the 3' UTR of the PGK1 gene directs the 
localization of hybrid GFP mRNAs to free cytoplasmic polysomes indicating the importance 
of the RNA structure in export events (Corral-Debrinski et al., 2000). The RPR1 terminator 
region may direct the ribozymes to remain in the nucleus where the RPR1 function is 
required. Thus, it could be demonstrated that the activity of the exported ribozyme was more 
efficient. Therefore, the export of ribozymes efficiently and specifically to cytoplasm has 
been used to obtain significantly higher cleavage activity of hammerhead ribozymes in 
mammalian cells (Kuwabara et al., 2001; Kato et al, 2001). 
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5.6 High target gene expression 
 
 PGK1 is a highly expressed gene (Holland & Holland, 1978). The long half-life of its 
transcripts was one of the major characteristic evaluated as important in allowing the 
detection of intact cleavage products. However, the high level of expression for this gene 
could also affect the detection of cleavage activity. The range of reduction that must be 
reached in order to observe an effect in the glycerol production is not known. Perhaps, the 
multiple turnovers could not be satisfied with our ribozyme expression system despite high 
levels of transcription reached. Nevertheless, this system could be tested and more efficiently 
exploited when the cleavage activity is thought to suppress a gene with slower level of 
expression. 
 
 
5.7 Differential expression of transcripts 
 
In Saccharomyces cerevisiae the transition from logarithmic growth to the stationary 
phase is accompanied with a 50% decrease in total RNA and a decline in the ribosomes to less 
than 25% of the maximum amount (Sethy et al., 1995). The PGK1 mRNAs levels decreased 
as cells entered the stationary phase (Dickson & Brown, 1998). Starvation involves a 
transition from active growth to growth arrest and involves changes in multiple environmental 
parameters over time such as cell density, pH, and the successive depletion of nutrients which 
contribute to the complex temporal pattern of gene expression (Gasch et al., 2000). 
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The RNAs transcribed by pol III are not limiting for cell growth under normal conditions 
but are available for cellular processes including protein secretion, synthesis and RNA 
processing. However, some reports have determined that the tRNA transcription is down 
regulated during transition from logarithmic to stationary phase growth (Sethy et al., 1995). 
Therefore, the fact of almost no effect determined on the PGK1 activity may be explained due 
to the high expression of the PGK1 gene in the early logarithmic phase used for this analysis. 
Likewise in the stationary phase the catalytic activity could be measured as glycerol 
production due to the decreased level of PGK1 transcripts present and the maintenance of 
enough ribozyme transcripts under these conditions where glycerol is accumulated. 
Furthermore, it must be considered that the partial influence on the PGK1 activity could 
be also observed with a cleaved mRNA molecule which generates a truncated protein in vivo, 
which could contribute to the total protein activity. Considering that the Rz1 was designed to 
cleave at the start translation codon (See chapter 4.1), it is not possible that the cleavage 
activity mediated by Rz1 generates a truncated PGK1 which is still active. A report in human 
cells has shown the substantial accumulation of a truncated protein of Apolipoprotein B 
mRNA caused by cleavage activity of hammerhead ribozymes; in this case, most of the 
truncated protein was degraded intracellularly (Wang et al., 1999). 
The undetected ribozyme activity determined by Pgk1 activity assays could be an effect of 
the method principle itself. This method is based on the indirect measuring of the NADH 
oxidation coupled to the phosphoglycerate kinase reaction. The NADH consumption might 
also be caused by other enzymes present in the system what could leads to unspecific values.
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5.8 PGK1 and glycolysis 
 
The reduction of the PGK1 to influence the glycolytic pathway in order to increase the 
glycerol production seems to depend on many factors. The level of glycerol accumulated in 
the transformants compared with the controls strains does not differ significantly (chapter 
4.8). A 20% enhancement in the glycerol yield was reached in the transformants. Decreasing 
the PGK1 mRNA level to influence the glycolytic flux may not cause the expected 
physiology of lower glycolysis rate. Some experiments showed that the glycolytic flux is 
conditionally correlated to the ATP concentration. A strong negative correlation between the 
glycolytic flux and the intracellular ATP content, i.e. a higher rate of glycolysis was not 
accompanied with an increased level of glycolytic enzymes (Larsson et al., 1997). On the 
other hand, the overexpression of individual glycolytic enzymes in yeast did not increase 
fermentation rates (Shaaff et al., 1989). These contrasting views of this metabolic pathway 
confirm the existence of many other factors that control the metabolic flux such as the ATP 
consumption and the cytosolic redox balance. Furthermore, the metabolic control analysis 
revealed that numerous metabolites as well as ATP/ADP and NADH/NAD+ ratios affect 
glycerol formation. The metabolites concentrations vary in magnitude as does the relative 
proportion at different phase of growth. Thus, the parameters that affect the glycerol flux 
early in fermentation have not the same extent of influence later (Cronwright et al., 2002). 
Moreover, under fermentative conditions the levels of pyruvate kinase and other 
glycolytic enzyme influence both the rate and direction of the carbon flux. The consequences 
of disturbing the transcriptional and post-transcriptional regulation of PYK1, PFK1 and PFK2 
genes as well as the Pyk1 and Pfk1 levels were that under fermentative growth conditions, the 
gene regulation plays a minor role in the control of the glycolytic flux. Pyk1 had unexpected 
control effects. A decrease in Pyk1 caused an increase in the TCA cycling, i.e. an apparent 
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switch from fermentative to respiratory metabolism via an unknown mechanism (Pearce et al., 
2001). Thereby, the understanding of the factors which control the in vivo metabolic flux is 
relatively limited. 
 
 
5.9 No evidence for cleavage products 
 
 In RNA decay studies, it was observed that PGK1 mRNAs are stable due to the 
sequence context of the PGK1 translation start codon. The 3' UTR has no influence on the 
RNA decay. The regions around the start codon are sensitive to changes and this 
destabilization brought about a reduction on the translational efficiency (LaGrandeur & 
Parker, 1999). This report might be consistent with the fact that no 3'-cleavage product was 
found in Rz1 transformants by primer extension (chapter 4.9). The Rz1 was designed for 
cleaving the PGK1 mRNA at a site including the start codon. Thus, the probability of 
detecting the 5'-cleavage product (about 40 nt) after isolation is low since it could be exposed 
to a rapid 5'-to-3' exonucleolytic degradation. 
 The in vivo assays revealed an enhancement in the glycerol production when Rz1 was 
used as catalytic RNA. However, this effect could be caused by an anti-sense activity without 
cleavage by the ribozyme. This might also explain the absence of the 3'-cleavage product 
detected by northern blot and primer extension assays (Chapters 4.6.2.2 and 4.9). 
Nevertheless, considering that the ribozyme was inserted into the RPR1 leader, an antisense 
activity due to 15nt (8 and 7 nt for each helix) in relation to the whole expressed molecule (ca. 
165 nt) is questionable. A cleavage reaction should take less time to act than an antisense 
binding in order to reduce the gene expression. The ribozyme and target secondary structures 
should interfere to capture the target for longer times in order to avoid the translation process. 
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The possible use of an inactive RZ1 form could help to determine the factor involved in the 
detected ribozyme activity. 
In the northern blot assays, the absence of cleavage products and the similar RNA 
expression detected in the transformants and control strains might be an effect of the low 
resolution of the technique. The wild-type PGK1 mRNA is only 40 nt longer than the cleaved 
RNA, thus this difference is difficult to be confirmed by this method. 
 
This approach has also been reported in other systems where the hammerhead ribozymes 
do not significantly reduce the protein expression. A hammerhead ribozyme which self cleave 
a ß-galactosidase reporter has been analyzed. In E. coli the in vivo efficiency of this ribozyme 
was 45-50% in spite of the good catalytic activity found in vitro with 70-80% efficiency. 
Moreover, northern blot analyzes were unable to detect cleavage products. The hammerhead 
ribozymes ability appeared also weak or nonexistent for the tested systems which also give an 
impression of the difficulties in detecting in vivo ribozyme activity (Drew et al., 1999). 
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5.10 Intracellular Ribozyme applications 
 
In yeast, most of the positive advances have been carried out with hammerhead ribozymes 
acting in cis for studying yeast RNA processing in vivo and for optimization of in vitro 
transcription of yeast transcripts (Duevel et al., 2002; Fechter et al., 1998). However in vivo 
cis-acting activity has been related with suppression of gene expression by interfering with 
splice site selection or translation initiation and not in vivo cleavage of the transcripts 
(Castanotto et al., 1998, Yim et al., 2000). 
Only a few cases of in vivo detectable cleavage products have been reported. Ferbeyre et 
al. (1996) have suggested that these negative results could be explained due to the fact that the 
yeast metabolism is very fast to observe a ribozyme–based cleavage activity; only when the 
cell-cycle was arrested, a hammerhead cleavage action was promoted. This factor could also 
be observed in the analysis of glycerol production. The measuring was carried out at the 
stationary phase where the cell-cycle is arrested. Hence, the influence on the PGK1 
expression was detected at the stationary phase but no clear evidence was found at 
logarithmic phase of growth. 
In S. cerevisiae, trans-acting ribozymes were reported with 100% efficiency in vivo when 
localization signals were added to ribozymes (Samarzky, 1999). Many protein factors are 
involved in the intracellular processing and transport on mRNAs immediately after 
transcription. Such factors could inhibit the binding of ribozymes with the target in the 
nucleus and the transport of mRNA to the cytoplasm seems to be more rapid than the attack 
by nuclear ribozymes (Koseki et al., 1999). Therefore, the knowledge and new advances of 
RNA structure and its physical cellular localization as well as transport/export machinery, are 
important to ensure co-localization and like this to have access to the tools for creation of 
models for high efficient suppression mediated by ribozymes in yeast. 
 97 
 Interestingly, in a recent publication, Khvorova and colleagues (2003) could show that 
the minimal sequence conserved hammerhead-ribozyme motif is sufficient to support a 
cleavage at high Mg2+ concentrations but not at low Mg2+ concentrations characteristic of 
intracellular environments. The hammerhead ribozyme requires non-conserved sequence 
elements outside of the conserved catalytic core to allow intracellular cleavage activity. These 
elements should stabilize the hammerhead ribozyme in an active conformation via tertiary 
interactions. Hammerhead ribozymes stabilized by such interactions cleave efficiently at 
physiological Mg2+ concentrations and are functional in vivo. In this work, the enhancement 
of glycerol production by application of anti-sense hammerhead ribozymes was only 20%. 
The low efficiency achieved could also be a consequence of the low intracellular Mg2+ 
concentrations of yeast cells. The use of stabilized hammerhead ribozyme to achieve good 
efficiency in the in vivo cleavage activity could be also tested as a new tool to reduce gene 
expression in yeast. 
 
The application of ribozyme in mammalian cells has been extensively tested. Trans-
cleaving ribozymes have been used in a small number of patients with infectious diseases and 
cancer. The delivery of ribozymes to the patients has been either by gene therapy methods or 
by direct injection of a synthetic ribozyme. The huge progresses in gene therapy application 
has been carried out in individuals with the human immunodeficiency virus (HIV), where 
CD4+ cells from the patient were transfected with retroviral vectors carrying anti HIV-
ribozymes ex vivo and infused into the patient. Three synthetic ribozymes have been directed 
to target RNAs that are associated with induction or cancer progression; the ribozyme directed 
against the flt-1 mRNA, which encodes the high affinity receptor for the angiogenic protein 
vascular endothelial factor (VEGF), has been evaluated in breast and colorectal cancer. The 
other two targets correspond to the human epidermal growth-factor receptor type 2 which is 
overexpressed in breast cancer and the hepatitis C virus (HCV), which is associated with liver 
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cirrhosis and hepatocellular carcinoma. Most of the critical factors found for an effective 
therapy are the ability to deliver ribozymes into the appropriate cells in vivo, as well as both 
level and duration of the target inhibition (Sullenger & Gilboa, 2002). Efficient ribozyme 
delivery, efficient high expression, co-localization of the ribozyme with the target, specificity 
of ribozyme for the desired mRNA, and an enhancement of the ribozyme-mediated substrate 
turnover are the obstacles which must be overcome for ribozymes to become generally useful 
surrogate genetic tools and realistic therapeutic agents (Castanotto et al., 2002).  
Recently, in mammalian cells to improve the efficiency of ribozymes in vivo a novel 
ribozyme with the ability to access and cleave at the specific target site has been created 
through the combination of the hammerhead ribozymes with the unwinding activity of the 
endogenous RNA helicase elF4AI. To connect the helicase to the ribozyme a poly(A) 
sequence was added to the 3' end of the ribozymes. This sequence is a naturally occurring 
RNA motif of the RNA helicase. Thus, targets on the mRNA previously inaccessible to 
cleavage were effective substrates for these ribozymes (Kawasaki & Taira, 2002). For yeast 
cells, this could also be a new approach for the generation of effective ribozymes using the 
helicase activity to enhance the cleavage efficiency in vivo. 
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6 Summary and future prospects 
 
In this work, a novel strategy was developed to decrease the expression of the PGK1 gene 
encoding the phosphoglycerate kinase of the glycolytic pathway by trans-acting hammerhead 
ribozymes. We selected and designed ribozymes for cleavage of the PGK1mRNA based on 
the prediction of its secondary structure. To deliver the ribozymes three different systems 
were tested. These systems required the creation of a pgk1 knock-out strain and plasmid 
constructs expressing PGK1/Ribozyme to achieve a stable accumulation of ribozymes co-
localizing with the target mRNA. The ribozymes were inserted into the RPR1 cassette using 
the pIIIEx423 RPR plasmid to allow high ribozyme expression. RPR plasmids contain the 
intragenic polymerase III promoter from the S. cerevisiae RNase P RNA gene (RPR1). The 
fusion of this leader to RNAs leads to stable accumulation of these molecules. In order to 
analyze the ribozyme trans-cleavage activity and its effects on the polymerase II dependent 
expression of PGK1, different techniques to investigate the cleavage activity were applied 
(northern blot, primer extension, Pgk1 activity assay and glycerol production analysis). 
The computer prediction supported by in vitro experiments is an initial step of the target 
selection. The ribozyme cleavage analyses confirmed the Rz site located at the start 
translation codon as accessible and efficient for the design of trans-acting hammerhead 
ribozymes. This site contains the consensus sequence AUGUC found in many yeast genes. 
Furthermore, the 3' untranslated region of the target gene, which contains cis sequences to 
specifically localize the transcript, is useful in ribozyme design. The fusion of the PGK1 
3’untranslated region to the Ribozyme which is directed to the consensus sequence AUGUC 
lead to a better result of ribozyme activity in terms of glycerol production. Thus, its use in 
trans-ribozyme delivery has been newly confirmed. As a rule, a combination of both 
sequences can be feasible for ribozyme design. Likewise, the northern blot analyses 
confirmed the use of the RPR1 leader as useful for high ribozyme expression. The secondary 
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structure of the RPR1 leader did not interfere with the in vivo and in vitro cleavage activity of 
the ribozymes. 
The understanding and knowledge of RNA metabolism seem to be an important issue for 
developing effective ribozyme design in yeast. The co-localization of ribozyme and target 
genes on the same plasmid does not guarantee cleavage activity when different transcription 
machineries play a role in their gene expression. The spatial distribution of polymerases II and 
III systems and the nuclear organization when transcription takes place, hampers an efficient 
interaction between target and ribozymes. The numerous proteins and factors binding the 
RNA, either in processing and trafficking, as well as the transport of ribozymes from nucleus 
to cytoplasm and the high level of expression are all important factors to be considered for 
designing more efficient ribozymes. Moreover, the use of high-copy-number episomal 
plasmids caused reduced yeast vitality that complicated the determination of the ribozyme 
effect. 
Thus, to avoid this effect the future work should be focused on the creation of integrative 
vectors for delivery of the optimized ribozyme (RPR-cassette and 3' untranslated region). The 
use of more than one ribozyme-expression-cassette into integrative vectors could ensure a 
high expression level. Furthermore, it would be favorable to select a reporter target gene that 
allows direct determination of the expression level. The gene encoding the green fluorescence 
reporter-protein (GFP) should be useful as a target gene to test the ribozyme catalytic activity. 
Moreover, the trans-acting hammerhead ribozyme design might also consider the stabilization 
by sequence elements outside the conserved core to allow efficient cleavage in vivo (see also 
Khvorova et al., 2003). 
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7 Zusammenfassung und Ausblick 
In der vorliegenden Arbeit wurde eine neue Strategie entwickelt, um die Expression des 
PGK1 Gens, das für die Phosphoglycerat-Kinase der Glycolyse kodiert, mittels trans-
agierenden Hammerhead Ribozymen zu verringern. Die Ribozyme wurden anhand der 
Computer vorausgesagten Sekundärstruktur von PGK1mRNA konzipiert und ausgewählt. Es 
wurden drei verschiedene Systeme getestet, um die Ribozyme an ihren Bestimmungsort zu 
bringen. Diese Systeme machten die Erstellung eines pgk1 knock-out Stamms und die 
Entwicklung von PGK1/Ribozym-exprimierenden Plasmiden nötig, um eine stabile 
Akkumulation von Ribozymen und die Co-Lokalisation mit der Ziel mRNA zu erreichen. Um 
einen hohen Expressionslevel der Ribozyme zu gewährleisten, wurden die Ribozyme unter 
Verwendung des pIIIEx423 RPR Plasmids in dessen RPR1 Kassette eingefügt. RPR Plasmide 
enthalten den intragenischen Polymerase III Promotor des S. cerevisiae RNase P RNA Gens 
(RPR1). Die Fusion dieser Sequenz mit Ribozym-Sequenzen führt zu einer stabilen 
Akkumulation der RNA-Moleküle. Um die Transspaltungs-Aktivität der Ribozyme und deren 
Effekt auf die Polymerase II abhängige Expression des PGK1 Gens zu untersuchen, wurden 
verschiedene Techniken angewendet, die es erlauben, die Spaltungsaktivität zu messen 
(Northern Blot, Primer Extension, Pgk1 Aktivitätsmessungen, Analyse der 
Glycerinproduktion). 
Computergestützte Vorhersagen der Sekundärstruktur, die durch in vitro Experimente 
ergänzt wurden, sind ein erster Schritt bei der Auswahl von Ziel-RNAs. Spaltungs-
Untersuchungen der Ribozyme bestätigten, dass die am Startcodon der Translation lokalisierte 
Sequenz als ein zugängliches und effizientes Ziel zur Entwicklung von trans-agierenden 
Hammerhead Ribozymen genutzt werden kann. Diese Sequenz ist häufig als Consensus 
Sequenz AUGUC am Beginn von Hefe-Genen zu finden. Des weiteren ist die 3’ nicht-
translatierte Region des Zielgens, die cis Sequenzen enthält, die zur spezifischen Lokalisation 
des Transkripts führen, nützlich in der Ribozymentwicklung. Die Fusion der 3’ nicht-
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translatierten Region des PGK1 Gens mit dem Ribozym für den AUGUC Consensus führte zu 
einer erhöhten Glycerinproduktion, was auf eine verbesserte Spaltungsaktivität hindeutet. Der 
positive Effekt der 3’ nicht-translatierten Region in der Lokalisation von trans-agierenden 
Ribozymen konnte somit bestätigt werden. In der Regel ist eine Kombination der beiden 
genannten Sequenzbereiche zum Ribozymdesign sinnvoll. Auch bestätigte die Analyse durch 
Northern Blots, dass die Verwendung der RPR1 Sequenz zur erhöhten Expression von 
Ribozymen führt. Die Sekundärstrukur der RPR1 Sequenz behinderte die in vivo und in vitro 
Spaltungsreaktion der Ribozyme nicht. 
Das Verständnis und Wissen über den RNA Stoffwechsel sind eine wichtige Grundlage 
für die Entwicklung effektiv spaltender Ribozyme in Hefe. Die Co-Lokalisation von 
Ribozym- und Ziel Gen auf demselben Plasmid garantieren nicht eine hohe 
Spaltungsaktivität, wenn für die RNAs verschiedene Transkriptionssysteme verwendet 
werden. Die räumliche Verteilung der Polymerase II und III Systeme und die Organisation im 
Kern während der Transkription lassen eine effiziente Interaktion zwischen Ziel-Sequenz und 
Ribozym kaum zu. Zahlreiche Proteine und Faktoren, die in der Prozessierung und beim 
Transport an die RNA binden, wie auch der Transport von Ribozymen vom Kern zum 
Cytoplasma und ein hoher Expressionslevel sind wichtige Größen, die die Wirkung eines 
Ribozyms beeinflussen. Hierbei muss allerdings berücksichtigt werden, dass die Verwendung 
hochexprimierender, episomaler Vektoren zu einer Reduzierung der Vitalität der Hefe führen 
kann, die die Bestimmung der Ribozymwirkung erschwert. 
Es wäre daher interessant, in weiterführenden Arbeiten optimierte Ribozyme (RPR-
Kassette, 3’ nicht-translatierte Region) in das Hefegenom zu integrieren, um die genannten 
Effekte zu vermeiden. Die Integration von mehr als einer Ribozymexpressionskassette könnte 
einen hohen Expressionslevel sichern. Darüber hinaus wäre die Auswahl eines Zielgens 
wünschenswert, dessen Expressionsreduktion einfacher meßbar ist. Das GFP Gen, welches 
für das „Green Flurescent Protein“ kodiert, könnte ein nützliches Ziel sein, um 
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Ribozymaktivität zu testen. Seit kurzem ist auch bekannt, dass die trans-agierenden 
Hammerhead Ribozyme durch Sequenzelemente außerhalb des konservierten Kerns 
stabilisiert werden können, was zu einer wesentlich besseren Spaltung in vivo führt (siehe 
Khvorova et al., 2003). 
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9 Appendix 
Ligation
 
Figure A 1: Construction of the pRS416 vector carrying PGK1 gene and the ribozyme 
expression cassette. Abbreviations: AMP: ampicilline resistance gene, HIS4: histidinol 
dehydrogenase, PGK1: phosphoglycerate kinase gene, RPR1: Rnase P RNA ribozyme 
expression cassette, URA3: uracil 3 gene. 
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PCR
Ligation
Restriccion
1
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1631
2446
3261
4076
4891
5706
6521
7336
pRS416 PGK1
8150 bp
URA3
PGK1
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SacII
XhoI
BamHI
 
 
Figure A 2: Construction of the pRS423 RPR1 vector carrying the terminator region of PGK1. 
Abbreviations: AMP: ampicilline resistance gene, HIS4: histidinol dehydrogenase, PGK1: 
phosphoglycerate kinase gene, PGK1 3'UTR. Phosphoglycerate kinase 3' untranslated region, 
RPR1: Rnase P RNA ribozyme expression cassette, URA3: uracil 3 gene. 
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pGEM®-T Vector sequence reference points: 
 
Base pairs 3000 
T7 RNA polymerase transcription initiation site 1 
multiple cloning region 10-113 
SP6 RNA polymerase promoter (-17 to +3) 124-143 
SP6 RNA polymerase transcription initiation site 126 
pUC/M13 Reverse Sequencing Primer binding site 161-177 
lacZ start codon 165 
lac operator 185-201 
beta-lactamase (Ampr) coding region 1322-2182 
phage f1 region 2365-2820 
lac operon sequences 2821-2981, 151-380 
pUC/M13 Forward Sequencing Primer binding site 2941-2957 
T7 RNA polymerase promoter (-17 to +3) 2984-3 
 
 
Figure A 3: pGEM®-T Vector Map. This vector has been linearized with EcoR V at base 51 
(*) and a T-residue has been added to both 3'-ends. The pGEM®-T Vector is prepared by 
cutting Promega's pGEM®-5Zf(+) Vector with EcoRV and adding a 3´ terminal thymidine to 
both ends. These single 3´-T overhangs at the insertion site greatly improve the efficiency of 
ligation of a PCR product into the plasmid by preventing recircularization of the vector and 
providing a compatible overhang for ligation of PCR products generated by certain 
thermostable polymerases. 
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1
490
979
1468
1957
2446
2935
3424
3913
4402
pRS416
4898 bp
BssHII 1970
BssHII 2143
EcoRI 2052
EcoRV 605
EcoRV 2048
SacII 2101
SpeI 2076
MCS
Ura 3
ARS4/CEN6
Ampr
lacZ
 
 
 
 
Figure A 4: Plasmid map of the yeast shuttle vector pRS416. The pRS416 vectors are yeast 
centromere plasmids (YCps) derived from the Yip vectors. These vectors include a 
CEN6/ARS4 cassette that provides mitotic stability and the ability to be autonomously 
replicated. 
Transcription start point
EcoRI Terminator
+1
RPR1 Promoter
10 20 30 40 50
.. ..| .... | .. ..|. ... | .. ..|. ...| .. ..|. ...| ... .|. ...|
AGTCTGTTTC TTTTCGTTTC GATTGTTTTA CGTTTGAGGC CTCGTGGCGC
60 70 80 90 100
.. ..| .... | .. ..|. ... | .. ..|. ...| .. ..|. ...| ... .|. ...|
ACATGGTACG CTGTGGTGCT CGCGGCTGGG AACGAAACTC TGGGAGCTGC
110 120 130 140 150
.. ..| .... | .. ..|. ... | .. ..|. ...| .. ..|. ...| ... .|. ...|
GATTGGCAGA ATTCCCCCAT ATCCACTTCC AATTTAATCT TTCTTTTTTA
160 170
.. ..| .... | .. ..|. ... | .. ..|. ..
ATTTTCACTT ATTTGCGATA CAGAAAGA
 
Figure A 5: Sequence of pol III promoter construct published by Good and Engelke (Good & 
Engelke, 1994). The sequence of the RPR1 promoter construct is given from upstream of the 
transcription start point (marked with bent arrows). The EcoRI insertion site for Ribozyme 
genes and terminator sequence are marked with over lines. 
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10 20 30 40 50
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
pIIIEx423 RPR Rz1 8/7 CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
pIIIEx423 RPR Rz1 11/10 CTGTCTCTATACTCCCCTATANTCTGTTTNTTTTCGTTTCGATTGTTTTA
pIIIEx423 RPR Rz1 14/13 CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
Rz1 14/13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
60 70 80 90 100
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
pIIIEx423 RPR Rz1 8/7 CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
pIIIEx423 RPR Rz1 11/10 CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
pIIIEx423 RPR Rz1 14/13 CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
Rz1 14/13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
110 120 130 140 150
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR AACGAAACTCTGGGAGCTGCGATTGGCAG~~~~~~~~~~~~~~~~~~~~~
pIIIEx423 RPR Rz1 8/7 AACGAAACTCTGGGAGCTGCGATTGGCAG~~~~~~~~ATTAGATAAACTG
pIIIEx423 RPR Rz1 11/10 AACGAAACTCTGGGAGCTGCGATTGGCAG~~~~AATTTGAAGATAAACTG
pIIIEx423 RPR Rz1 14/13 AACGAAACTCTGGGAGCTGCGATTGGCAGAATTTCTTTGAAGATAAACTG
Rz1 14/13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~AATTTCTTTGAAGATAAACTG
160 170 180 190 200
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~AATTCCCCCATATCCA
pIIIEx423 RPR Rz1 8/7 ATGAGTCCGTGAGGACGAAACATTGTTG~~~~~~AATTCCCCCATATCCA
pIIIEx423 RPR Rz1 11/10 ATGAGTCCGTGAGGACGAAACATTGTTTTAG~~~AATTCCCCCATATCCA
pIIIEx423 RPR Rz1 14/13 ATGAGTCCGTGAGGACGAAACATTGTTTTATATGAATTCCCCCATATCCA
Rz1 14/13 ATGAGTCCGTGAGGACGAAACATTGTTTTATATG~~~~~~~~~~~~~~~~
210 220 230 240 250
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR ACTTCCAATTTAATCTTTCTTTTTTAATTTTCACTTATTTGCGATACAGA
pIIIEx423 RPR Rz1 8/7 ACTTTCAATTTAATCTTTCTTTTTTAATTTTCACTTATTTGCGAAACAAA
pIIIEx423 RPR Rz1 11/10 ACTTCCAATTTAATCTTTCTTTTTTAATTTTCACTTATTTGCGATACAGA
pIIIEx423 RPR Rz1 14/13 ACTTCCAATTTAATCTTTCTTTTTTAATTTTCACTTATTTGCGATACAGA
Rz1 14/13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
260 270 280 290 300
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR AAGAAAAAAGCGATAGTAACTATTGAATTTTGTTTGGATTTGGNTAGATT
pIIIEx423 RPR Rz1 8/7 AAGAAAAAAGCGATAGTAACTATTGAATTTTGTTTGGATTTGGTTNGATA
pIIIEx423 RPR Rz1 11/10 AAGAAAAAAGCNATAGTAACTATTGAATTTTGTTTGGATTTGGTTAGATT
pIIIEx423 RPR Rz1 14/13 AAGAAAAAAGCGATAGTAACTATTGAATTTTGTTTGGATTTGGTTAGATT
Rz1 14/13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
.
pIIIEx423 RPR A
pIIIEx423 RPR Rz1 8/7 A  
 
Figure A 6: Sequences of pIIIEx423 RPR plasmids used for ribozyme delivering containing 
sequences coding for Rz1 (located at 130 to180 nt), these sequences were compared with 
RZ114/13 sequence used for cloning. 
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10 20 30 40 50
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR Rz1 8/7 CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
pIIIEx423 RPR Rz1 PGK1 CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
PGK1 3'UTR ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
60 70 80 90 100
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR Rz1 8/7 CGTTTGAGGCCTNGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
pIIIEx423 RPR Rz1 PGK1 CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
PGK1 3'UTR ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
110 120 130 140 150
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR Rz1 8/7 AACGAAACTCTGGGAGCTGCGATTGGCAGATTAGATAAACTGATGAGTCC
pIIIEx423 RPR Rz1 PGK1 AACGAAACTCTGGGAGCTGCGATTGGCAGATTAGATAAACTGATGAGTCC
PGK1 3'UTR ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
160 170 180 190 200
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR Rz1 8/7 GTGAGGACGAAACATTGTTGAATTCCCCCATATCCAACTTTCAATTTAAT
pIIIEx423 RPR Rz1 PGK1 GTGAGGACGAAACATTGTTGAATTCCGGCTTTCTTATCCGAAAAGAAATA
PGK1 3'UTR ~~~~~~~~~~~~~~~~~~~~~~~~~~~GCTTTCTTATCCGAAAAGAAATA
210 220 230 240 250
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR Rz1 8/7 CTTTCTTTTTTAATTTTCACTTATTTGCGAAACAAAAAGAAAAAAGCGAT
pIIIEx423 RPR Rz1 PGK1 AATTGAATTGAATTGAAATCGATAGATCAATTTTTTTCTTTTCTCTTTCC
PGK1 3'UTR AATTGAATTGAATTGAAATCGATAGATCAATTTTTTTCTTTTCTCTTTCC
260 270 280 290 300
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR Rz1 8/7 AGTAACTATTGAATTTTGTTTGGATTTGGTTNGATAA~            
pIIIEx423 RPR Rz1 PGK1 CCATCCTTTACGCTAAAATAATAGTTTATTTTATTTTTTGAATATTTTTT
PGK1 3'UTR CCATCCTTTACGCTAAAATAATAGTTTATTTTATTTTTTGAATATTTTTT
310 320 330 340 350
.. .. |.. .. |. .. .| .. .. |. .. .| .. .. |. .. .|. .. .| .. .. |. .. .|
pIIIEx423 RPR Rz1 8/7                                                   
pIIIEx423 RPR Rz1 PGK1 ATTTATATACGTATATATAGACTATTATTTATCTTTTAATGATTATTAAG
PGK1 3'UTR ATTTATATACGTATATATAGACTATTATTTATCTTTTAATGATTATTAAG
360
.. .. |.. .. |. .. .| ..
pIIIEx423 RPR Rz1 8/7                  
pIIIEx423 RPR Rz1 PGK1 ATTTTTATTAAAAAAAA
PGK1 3'UTR ATTTTTATTAAAAAAAA
 
 
Figure A 7: Comparison between Rz1 8/7 containing plasmids used for ribozyme expression 
with different terminator ends. pIIIEx423 RPR Rz1 8/7 + PGK1 3’UTR was compared as 
well with the corresponding sequence to PGK1 3’-untranslated used for cloning, available by 
Saccharomyces genome database, located at 177 to 356 nt. 
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10 20 30 40 50
....|....|....|....|....|....|....|....|....|....|
pIIIEx423 RPR Rz5 CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
pIIIEx423 RPR CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
RZ5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
60 70 80 90 100
....|....|....|....|....|....|....|....|....|....|
pIIIEx423 RPR Rz5 CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
pIIIEx423 RPR CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
RZ5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
110 120 130 140 150
....|....|....|....|....|....|....|....|....|....|
pIIIEx423 RPR Rz5 AACGAAACTCTGGGAGCTGCGATTGGCAGAATTTCCAATGGCTGATGAGT
pIIIEx423 RPR AACGAAACTCTGGGAGCTGCGATTGGCAGAA~~~~~~~~~~~~~~~~~~~
RZ5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~AATTTCCAATGGCTGATGAGT
160 170 180 190 200
....|....|....|....|....|....|....|....|....|....|
pIIIEx423 RPR Rz5 CCGTGAG-ACGAAACGTTGAAGAATTCCCCCATATCCAACTTCCAATTTA
pIIIEx423 RPR ~~~~~~~~~~~~~~~~~~~~~~~~TTCCCCCATATCCNACTTCCAATTTA
RZ5 CCGTGAGGACGAAACGTTGAAG~~~~~~~~~~~~~~~~~~~~~~~~~~~~
210 220 230 240 250
....|....|....|....|....|....|....|....|....|....|
pIIIEx423 RPR Rz5 ATCTTTCTTTTTTAATTTTCACTTATTTGCGATACAGAAAGAAAAAAGCG
pIIIEx423 RPR ATCTTTCTTTTTTAATTTTCACTTATTTGCGATACAGAAAGAAAAAAGCG
RZ5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
260 270 280 290 300
....|....|....|....|....|....|....|....|....|....|
pIIIEx423 RPR Rz5 ATAGTAACTATTGAATTTTGTTTGGATTTGGTTAGATTAGATATGGTTTC
pIIIEx423 RPR ATAGTAACTATTGAATTTTGTTTGGATTTGGNTAGATTAGATATGGGTTC
RZ5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
310 320 330
....|....|....|....|....|....|....
pIIIEx423 RPR Rz5 TCTTTATATTTACATGCTAAAAATGGGCTACACC
pIIIEx423 RPR TCTTTATATTTACATGCTAAAAATGGGCTACACC
RZ5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 
 
 
 
Figure A 8: Sequence comparison of pIIIEx423 RPR carrying Rz5 coding sequence, without 
ribozyme, and Rz5 sequence used. A punctual deletion, G, is observed at the catalytic core 
sequence located at 158 nt. 
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10 20 30 40 50
. .. . |. .. .| .. . .| .. .. | .. .. |. .. . |. .. .| . .. .| .. . .| .. .. |
pIIIEx423 RPR Rz9 CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
pIIIEx423 RPR CTGTCTCTATACTCCCCTATAGTCTGTTTCTTTTCGTTTCGATTGTTTTA
RZ9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
60 70 80 90 100
. .. . |. .. .| .. . .| .. .. | .. .. |. .. . |. .. .| . .. .| .. . .| .. .. |
pIIIEx423 RPR Rz9 CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
pIIIEx423 RPR CGTTTGAGGCCTCGTGGCGCACATGGTACGCTGTGGTGCTCGCGGCTGGG
RZ9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
110 120 130 140 150
. .. . |. .. .| .. . .| .. .. | .. .. |. .. . |. .. .| . .. .| .. . .| .. .. |
pIIIEx423 RPR Rz9 AACGAAACTCTGGGAGCTGCGATTGGCAGAATTAAGCCTTCTGATGAGTC
pIIIEx423 RPR AACGAAACTCTGGGAGCTGCGATTGGCAGAA~~~~~~~~~~~~~~~~~~~
RZ9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~AATTAAGCCTTCTGATGAGTC
160 170 180 190 200
. .. . |. .. .| .. . .| .. .. | .. .. |. .. . |. .. .| . .. .| .. . .| .. .. |
pIIIEx423 RPR Rz9 CGTGAGGACGAAACAGCGGCGAATTCCCCCATATCCAACTTCCAATTTAA
pIIIEx423 RPR ~~~~~~~~~~~~~~~~~~~~~~~TTCCCCCATATCCNACTTCCAATTTAA
RZ9 CGTGAGGACGAAACAGCGGCG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
210 220 230 240 250
. .. . |. .. .| .. . .| .. .. | .. .. |. .. . |. .. .| . .. .| .. . .| .. .. |
pIIIEx423 RPR Rz9 TCTTTCTTTTTTAATTTTCACTTATTTGCGATACAGAAAGAAAAAAGCGA
pIIIEx423 RPR TCTTTCTTTTTTAATTTTCACTTATTTGCGATACAGAAAGAAAAAAGCGA
RZ9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
260 270 280 290 300
. .. . |. .. .| .. . .| .. .. | .. .. |. .. . |. .. .| . .. .| .. . .| .. .. |
pIIIEx423 RPR Rz9 TAGTAACTATTGAATTTTGTTTGGATTTGGTTAGATTAAATATGGGTTCT
pIIIEx423 RPR TAGTAACTATTGAATTTTGTTTGGATTTGGNTAGATTAGATATGGGTTCT
RZ9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
310 320 330
. .. . |. .. .| .. . .| .. .. | .. .. |. .. . |. .
pIIIEx423 RPR Rz9 CTTTATATTTACATGCTAAAAATGGGCTACCC
pIIIEx423 RPR CTTTATATTTACATGCTAAAAATGGGCTACAC
RZ9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 
Figure A 9: Sequence comparison of pIIIEx423 RPR carrying Rz9 coding sequence with 
vector without ribozyme, and the expected Rz9 sequence used. 
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